Loading...
Dolutegravir — Export Intelligence Report
2025-Q4 · TransData Nexus
PHARMA TRADE INTELLIGENCE
INDIA EXPORT INTELLIGENCE REPORT
Dolutegravir
2025-Q4
Comprehensive analysis of India’s dolutegravir export trade — suppliers, buyers, prices, routes, and every shipment record.
241
Shipments
$37.59M
Trade Value
18
Suppliers
55
Buyers
47
Countries
Scan for online report
Talk to our analyst: +91 95950 78788
https://transdatanexus.com/pharmaceutical/dolutegravir
01
PART I — OVERVIEW
Executive Summary
At-a-glance KPIs, key findings, and strategic positioning of India’s dolutegravir trade — 2025-Q4
KEY TAKEAWAY
Dolutegravir 2025-Q4 exports total $37.6M across 47 countries, with HETERO LABS LTD commanding 45.6% market share.
TOTAL SHIPMENTS
241
2025-Q4
EXPORT VALUE
$37.6M
FOB USD
TOTAL QUANTITY
311.4M
units shipped
INDIAN SUPPLIERS
18
unique exporters
GLOBAL BUYERS
55
unique importers
DESTINATIONS
47
countries
MEDIAN UNIT PRICE
$0.087
per unit
TOP-5 SHARE
99.3%
of total USD
BRANDED SHARE
20.3%
49 shipments
DOSAGE FORMS
4
product types
6 KEY FINDINGS
1
HETERO LABS LTD is India's #1 Dolutegravir exporter with $17.1M (45.6% market share).→ §5, Indian Supplier Rankings
2
Dolutegravir reached 47 countries, with South Africa as the top destination ($11.4M).→ §4, Global Destination Map
3
Market concentration is high (HHI: 3015) — top 10 suppliers control 100.0% of exports.→ §5, Indian Supplier Rankings
4
89.1% of buyers (49 of 55) source from a single Indian supplier — potential poaching opportunities.→ §6, Global Buyer Rankings
5
Tablet dominates (81.5%) across 4 dosage forms.→ §7, Price Benchmarks
6
47 countries have ≤5 Indian suppliers — easy-entry markets for SME exporters.→ §9, Strategic Opportunities
WHO THIS REPORT IS FOR
S SUPPLIERS (Indian pharma exporters)
- See which buyers your competitors are shipping to, at what price, through which ports
- Identify buyers that are single-sourced (poaching opportunities)
- Benchmark your pricing and catalog vs the Top 25
B BUYERS (global importers)
- Discover which Indian exporters supply this product and what they sell
- Benchmark the price you are paying vs the market median by country and dosage
- Identify alternative suppliers with proven exports to similar destinations
Figure 1.1 HETERO LABS LTD leads in volume — how do 18 exporters compare on price × volume?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Every bubble is one Indian dolutegravir exporter. X-axis = shipment count; Y-axis = average unit price; bubble size = total revenue. Dashed lines split at the median — exporters in the top-right (Bulk Leaders) combine high volume with premium pricing.
HOW TO READ THIS REPORT
60 seconds
Scan this page — KPIs, thesis, flagship chart, top findings
5 minutes
Read every Key Takeaway line across §1–§9
30 minutes
Read sections tagged for your role ([S] or [B]) end-to-end
In depth
Drill into §10 for your country · supplier / buyer directories at end
02
PART I — OVERVIEW
About This Report
Data sources, methodology, trust signals, and what this Dolutegravir report covers
KEY TAKEAWAY
Every figure in this report is grounded in real commercial dolutegravir trade records. Data comes from official customs filings and public trade sources, runs through a multi-layer quality process, and lands in a clean, consistent report you can rely on.
S FOR SUPPLIERS
Every competitor benchmark, market share figure, and buyer list in this report comes from verified commercial shipments — not surveys or estimates. Use them with confidence when planning your next pitch.
B FOR BUYERS
Every supplier profile, price benchmark, and trade route in this report reflects what that supplier actually ships — real volumes, real destinations, real prices. Use them to qualify and compare Indian dolutegravir suppliers.
§2.1 Reporting parameters · the scope of this 2025-Q4 Dolutegravir India trade report
Product scope
Dolutegravir
All variants merged — branded and generic formulations of dolutegravir
Time period
2025-Q4
October, November, December 2025 — a single-quarter snapshot
Data sources
Official & public trade records
Government customs filings, public trade databases and licensed commercial feeds
Geography
India origin → global
Indian sea and air ports shipping to destination markets worldwide
Currency
USD (FOB)
Declared Free-on-Board value at the Indian port of loading
Shipments analysed
241
Every commercial dolutegravir trade record in the period, aggregated and deduplicated
§2.2 Our quality process · Figure 2.1
Figure 2.1 From raw trade records to a clean report — the four quality pillars.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Raw trade data (left) flows through four quality checks — source verification, format standardisation, entity matching, and deduplication — to produce the clean, reliable data (right) behind every chart and table in this report.
§2.3 Trust signals · what you can rely on in the numbers you read
DATA COVERAGE
10M+
Pharmaceutical trade records across the full TransData Nexus platform.
COUNTRIES
150+
Origin and destination countries covered in the global pharma trade database.
DATA ACCURACY
99.9%
Validation rate on core fields — supplier, buyer, product, quantity, value.
UPDATE FREQUENCY
Daily
Platform refresh cadence. This report is a snapshot from the same live data.
§2.4 Limitations · what the data does and does not tell you
WHAT THIS DATA DOES AND DOES NOT SAY
- Prices are at the Indian port of loading (FOB), not the final delivered cost in the destination country. Freight, insurance, import duty and local margin are not included.
- This is a single-quarter snapshot. Multi-quarter trends, year-over-year growth and historical comparisons are available on the full platform.
- A small number of records have incomplete transport mode or destination port fields; these appear blank in the shipment register but are still counted in totals.
- This report is a commercial intelligence tool, not a legal audit. For high-stakes decisions, cross-reference with the underlying trade records via the full platform.
03
PART II — MARKET STRUCTURE
Quarterly Trade Overview
Monthly trends, regional performance, and ranking shifts — 2025-Q4
KEY TAKEAWAY
2025-Q4 followed a v-curve: Oct $13.0M, Nov $12.3M, Dec $12.3M. Shipment counts rose across the quarter.
S FOR SUPPLIERS
Track which months your competitors were most active, which destinations rose or fell, and whether the Nov dip hit your segment. The bump charts show rank movement — watch for rivals climbing past you.
B FOR BUYERS
Identify whether your current Indian supplier maintained steady shipments through the quarter, or whether they pulled back. Steady suppliers during dips signal reliable partnerships.
1
$13.0M
Oct USD
46 shipments
2
$12.3M
Nov USD
-5.4% MoM
3
$12.3M
Dec USD
+0.3% MoM
4
V-curve
Q4 growth shape
Oct → Nov → Dec
Fig 3.1 Nov dipped 5.4% in USD but shipment count kept climbing.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Blue bars = monthly USD. Orange line = shipment count. When bars drop but line rises, average shipment value fell. Insight: Oct opened at $13.0M, making it the strongest month by value.
Fig 3.2 Q4 cumulative USD reached $37.6M.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: The curve shows the running total across the quarter. A steeper slope means that month contributed more revenue. Insight: The curve’s steepest section reveals which month drove the most trade value.
Fig 3.3 $708K dip in Nov, $32K recovery in Dec.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Blue bars = absolute monthly value. Red = month-over-month loss; green = gain. Insight: Nov’s dip was fully recovered by Dec.
Fig 3.4 Regional breakdown by month — which corridors swung most?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each coloured layer is one destination region. Layer height = USD in that month. Insight: The top region contributed the most, while the smallest region had the least volume.
§3.1 Monthly summary
| Oct | $13.0M | 46 shipments |
| Nov | $12.3M | 57 shipments |
| Dec | $12.3M | 138 shipments |
| Q4 Total | $37.6M | 241 shipments |
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
Fig 3.5 Top 10 destination countries by monthly USD rank — who’s rising?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each line traces a country’s monthly rank. Lines crossing = rank swaps. Insight: South Africa held #1 throughout the quarter.
Fig 3.6 Top 10 Indian exporters by monthly USD rank.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each line traces a supplier’s monthly rank. Flat = stable position; crossing = rank change. Insight: CIPLA LTD maintained its leading position.
04
PART II — MARKET STRUCTURE
Global Destination Map
Which countries import dolutegravir from India, how much they buy, and who supplies each market
KEY TAKEAWAY
South Africa absorbs 30.4% of India’s 2025-Q4 dolutegravir trade ($11.4M). Beyond the top 10 destinations, 47 countries have fewer than 5 Indian suppliers each — white-space markets where new entrants face minimal competition. Africa has 19 destination countries, the widest regional diversity.
S FOR SUPPLIERS
Use the flow map and lanes table to see which destinations your competitors dominate. For small and mid-size suppliers: look beyond the leading markets — the 47 countries in the long tail have fewer than 5 Indian suppliers each and low competitive barriers.
B FOR BUYERS
Find your country on the map to see how much dolutegravir India ships to your market, who the top suppliers are, and whether you’re in a concentrated or competitive corridor.
Asia
$1.4M
3.7% of trade
12 countries · 40 shipments
Europe
$265K
0.7% of trade
4 countries · 8 shipments
Americas
$1.9M
5.0% of trade
11 countries · 37 shipments
Africa
$34.1M
90.6% of trade
19 countries · 155 shipments
Oceania
$745
0.0% of trade
1 countries · 1 shipments
Fig 4.1 South Africa is the #1 corridor ($11.4M) — 30 flow arcs from India radiate across 5 continents.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: The world map shows every country colored by how much Indian dolutegravir it receives (light = low, dark = high). Orange arcs radiate from India to the top 30 destinations; arc thickness = USD value. All destinations are labeled with country name + USD.
§4.1 Top 10 bilateral trade lanes (India → destination) with top Indian suppliers
| # | Destination | Total USD | Ships | #1 Indian supplier | USD | #2 Indian supplier | USD | #3 Indian supplier | USD |
|---|---|---|---|---|---|---|---|---|---|
| 1 | South Africa | $11.4M | 40 | HETERO LABS LTD | $6.1M | EMCURE PHARMACEUTICALS LTD | $3.2M | CIPLA LTD | $2.1M |
| 2 | Tanzania | $4.8M | 4 | HETERO LABS LTD | $4.8M | MACLEODS PHARMACEUTICALS LTD | $3K | — | — |
| 3 | Zimbabwe | $2.9M | 35 | CIPLA LTD | $2.8M | EMCURE PHARMACEUTICALS LTD | $122K | MICRO LABS LTD | $44K |
| 4 | Kenya | $2.4M | 1 | HETERO LABS LTD | $2.4M | — | — | — | — |
| 5 | Cote d'Ivoire | $2.3M | 27 | CIPLA LTD | $2.3M | — | — | — | — |
| 6 | Mozambique | $2.2M | 1 | SUN PHARMACEUTICAL INDUSTRIES LTD | $2.2M | — | — | — | — |
| 7 | Gabon | $2.2M | 6 | M D PHARMACY | $2.2M | — | — | — | — |
| 8 | Nigeria | $1.8M | 9 | HETERO LABS LTD | $1.8M | — | — | — | — |
| 9 | Lesotho | $1.6M | 3 | EMCURE PHARMACEUTICALS LTD | $1.6M | — | — | — | — |
| 10 | Venezuela | $1.0M | 12 | CIPLA LTD | $1.0M | — | — | — | — |
Table 4.1 — Top 10 destination countries ranked by trade value, with the largest Indian suppliers for each market.
Fig 4.2 Asia leads at 3.7% of USD — but South Africa is the single largest market.
Region → country treemap
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Column width = region USD share. Within each column, cells are stacked by country, height = share within region.
§4.2 Destination concentration
30.4%
#1 country share
South Africa alone
63.6%
Top 5 share
5 of 47 countries
94.6%
Top 15 share
Long tail of 32 countries = 5.4%
HHI 1360
Destination HHI
Competitive spread
47
Countries served
Global pharma reach from India
19
Africa countries
Widest regional diversity
Source: TransData Nexus trade data platform
05
PART III — WHO’S IN THIS MARKET
Indian Supplier Rankings & Profiles
18 Indian exporters ranked by value — profiles, portfolios, and competitive intelligence
KEY TAKEAWAY
HETERO LABS LTD ($17.1M, 45.6% share) and CIPLA LTD ($9.1M) together control 69.7% of India’s 2025-Q4 dolutegravir trade. The top 5 suppliers hold 99.3%. 18 companies shipped at least once.
S FOR SUPPLIERS
Find your rank, your competitors’ ranks, and the gap in USD/share between you. The profile pages show each top supplier’s buyer portfolio, dosage mix and route map — your competitive-intelligence toolkit.
B FOR BUYERS
Find potential Indian dolutegravir suppliers ranked by size, catalog breadth and destination reach. The profile pages reveal which suppliers have proven trade lanes to your region.
Fig 5.1 HETERO LABS LTD leads by $8.1M over CIPLA LTD — top 18 Indian exporters ranked by trade value
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one Indian supplier ranked by USD. The (#N) shows their rank by shipment count — mismatches reveal pricing strategy. Insight: LEOWIN HEALTHCARE LLP is #15 by value but #10 by volume.
Fig 5.2 CIPLA LTD also leads by shipment count (117) but ranking shifts for volume-heavy players
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Same suppliers re-ranked by shipment count. The (#N) shows their rank by USD value. Insight: LEOWIN HEALTHCARE LLP moves from #10 by volume to #15 by value — fewer but higher-value shipments.
05
PART III — WHO’S IN THIS MARKET
Supply Landscape — Archetypes & Concentration
How India’s 18 dolutegravir suppliers split into strategic segments
KEY TAKEAWAY
5 suppliers (25%) generate 99.3% of total trade value. The market splits into four archetypes: Market Leaders, High-Value specialists, Volume players, and a long tail.
Fig 5.3 HETERO LABS LTD and CIPLA LTD sit in the leaders zone — high volume AND high value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bubble is one Indian supplier. X-axis = shipment count (log scale); Y-axis = total USD value (log scale); bubble size = revenue. Blue dashed lines split at the median. Market Leaders (top-right) combine high volume with high value. Premium Niche (top-left) ship fewer but higher-value consignments. Volume Players (bottom-right) compete on quantity. Long-Tail (bottom-left) are small or occasional exporters. Conclusion: the log scale reveals clear strategic clusters — use this map to identify where your company sits relative to competitors.
Fig 5.4 25% of suppliers = 99.3% of USD — classic concentration.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Top bar = supplier %, bottom bar = USD %. The gap = market concentration.
Product variety — how many formulations each supplier ships
| # | Supplier | Dosage forms | Countries | USD |
|---|---|---|---|---|
| 1 | HETERO LABS LTD | 2 | 16 | $17.1M |
| 2 | CIPLA LTD | 2 | 12 | $9.1M |
| 3 | MACLEODS PHARMACEUTICALS LTD | 2 | 11 | $70K |
| 4 | EMCURE PHARMACEUTICALS LTD | 1 | 8 | $6.1M |
| 5 | SUN PHARMACEUTICAL INDUSTRIES LTD | 1 | 4 | $2.8M |
| 6 | M D PHARMACY | 1 | 1 | $2.2M |
| 7 | MICRO LABS LTD | 1 | 2 | $131K |
| 8 | APPLE PHARMACEUTICALS | 1 | 1 | $8K |
| 9 | HOPEWELL SOLUTIONS | 1 | 1 | $6K |
| 10 | NIVIRA EXPORTS | 1 | 1 | $3K |
Table 5.1 — The more dosage forms a supplier ships, the more versatile their manufacturing capability.
05
PART III — WHO’S IN THIS MARKET
Supply Landscape — India Origin Geography & Concentration
Which Indian cities and states are the dolutegravir manufacturing hubs
KEY TAKEAWAY
Hyderabad and Parel Mumbai Maharashtra together account for $23.8M of India’s 2025-Q4 dolutegravir trade.
Fig 5.5 Hyderabad (1 exporters, $15.3M) and Parel Mumbai Maharashtra (1 exporters, $8.4M) are India’s dolutegravir capitals.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Orange bubbles mark major pharma hub cities; bubble size = USD value. Every hub labeled.
§5.1 Supplier concentration metrics
99.3%
Top 5 share
5 of 18 suppliers
100.0%
Top 10 share
10 of 18 suppliers
99.3%
Top 25% share
5 suppliers = 99% USD
HHI 3015
Supplier HHI
Concentrated
18
Total suppliers
shipped Dolutegravir in 2025-Q4
20+ cities
Indian hubs
Hyderabad and Parel Mumbai Maharashtra lead
§5.2 Coming next: 6 exporter deep-dive profiles
Each of the top 6 suppliers gets a dedicated 2-page profile with:
- 6 KPI cards — trade value, shipments, countries, buyers, avg ship value, branded share
- Dosage form breakdown — what formulations they ship
- Monthly trend — Oct / Nov / Dec trajectory
- Trade flow map — supplier → country → importer connections
- Buyer portfolio with lock-in analysis
SUPPLIER PROFILES IN THIS REPORT
| #1 | HETERO LABS LTD | $17.1M |
| #2 | CIPLA LTD | $9.1M |
| #3 | EMCURE PHARMACEUTICALS LTD | $6.1M |
| #4 | SUN PHARMACEUTICAL INDUSTRIES LTD | $2.8M |
| #5 | MACLEODS PHARMACEUTICALS LTD | $70K |
| #6 | HEET HEALTHCARE PVT LTD | $31K |
#1
EXPORTER PROFILE #1 OF 6
HETERO LABS LTD
Hyderabad · India’s #1 dolutegravir supplier by USD · 2025-Q4
2025-Q4 USD
$17.1M
45.6% market share
SHIPMENTS
44
avg $389K/ship
COUNTRIES
16
destination markets
BUYERS
12
8 single-sourced
BRANDED
32%
of shipments
DOSAGE FORMS
2
product types
TOP 10 DESTINATIONS
South Africa is the #1 market at $6.1M (35% of trade), followed by Tanzania at $4.8M. 16 countries served.
| # | Country | USD | Ships | Share |
|---|---|---|---|---|
| 1 | South Africa | $6.1M | 7 | 35.4% |
| 2 | Tanzania | $4.8M | 3 | 28.2% |
| 3 | Kenya | $2.4M | 1 | 13.9% |
| 4 | Nigeria | $1.8M | 9 | 10.7% |
| 5 | DR Congo | $702K | 2 | 4.1% |
| 6 | Vietnam | $606K | 5 | 3.5% |
| 7 | Botswana | $297K | 1 | 1.7% |
| 8 | Chile | $204K | 1 | 1.2% |
| 9 | Mauritania | $149K | 5 | 0.9% |
| 10 | Namibia | $20K | 1 | 0.1% |
MONTHLY TREND
Nov peaked at $8.9M. Dec was the weakest at $596K.
PRODUCT MIX
Tablet dominates at 73% of trade. Unknown (25.9%) and disopr are secondary formulations.
TOP BUYERS · 8/10 LOCKED IN
8 of 10 buyers source exclusively from this supplier — high lock-in with low competitive threat.
| Buyer | Country | USD | Status |
|---|---|---|---|
| Undisclosed buyer | Tanzania | $11.1M | N/A |
| THE MISSION DIRECTOR | Nigeria | $1.8M | ⚠ Locked |
| Undisclosed buyer | South Africa | $1.8M | N/A |
| MINISTRY OF HEALTH OF … | Tanzania | $1.4M | 2 sup. |
| HOANG DUC PHARMACEUTIC… | Vietnam | $606K | ⚠ Locked |
| SEVEN PHARMA CHILE SPA | Chile | $204K | ⚠ Locked |
| SECRETARIAT EXECUTIF N… | Mauritania | $149K | ⚠ Locked |
| UNDP | DR Congo | $64K | ⚠ Locked |
| COSPHARM | Namibia | $20K | ⚠ Locked |
| SEVEN PHARMA S.A | Peru | $14K | ⚠ Locked |
#1
EXPORTER PROFILE #1 OF 6 — TRADE FLOW MAP
HETERO LABS LTD — Supplier → Country → Importer
5 destination countries, top 5 importers per country
Fig 5.P1.3 South Africa absorbs $6.1M — the thickest ribbon.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 5 destinations and up to 2 importers per destination.
#2
2025-Q4 USD
$9.1M
24.1% market share
SHIPMENTS
117
avg $78K/ship
COUNTRIES
12
destination markets
BUYERS
12
10 single-sourced
BRANDED
2%
of shipments
DOSAGE FORMS
2
product types
TOP 10 DESTINATIONS
Zimbabwe is the #1 market at $2.8M (30% of trade), followed by Cote d'Ivoire at $2.3M. 12 countries served.
| # | Country | USD | Ships | Share |
|---|---|---|---|---|
| 1 | Zimbabwe | $2.8M | 31 | 30.4% |
| 2 | Cote d'Ivoire | $2.3M | 27 | 25.8% |
| 3 | South Africa | $2.1M | 25 | 23.3% |
| 4 | Venezuela | $1.0M | 12 | 11.1% |
| 5 | Republic of the Congo | $367K | 5 | 4.0% |
| 6 | Burkina Faso | $146K | 2 | 1.6% |
| 7 | Sri Lanka | $139K | 2 | 1.5% |
| 8 | Laos | $98K | 1 | 1.1% |
| 9 | Nicaragua | $89K | 2 | 1.0% |
| 10 | Tajikistan | $13K | 2 | 0.1% |
MONTHLY TREND
Dec was the strongest month, ending the quarter on a high at $7.3M.
PRODUCT MIX
Tablet dominates at 91% of trade. /tenofovir (7.8%) and Unknown are secondary formulations.
TOP BUYERS · 10/12 LOCKED IN
10 of 12 buyers source exclusively from this supplier — high lock-in with low competitive threat.
| Buyer | Country | USD | Status |
|---|---|---|---|
| MINISTRY OF HEALTH AND… | Zimbabwe | $2.8M | 2 sup. |
| PROGRAMME NATIONAL DE … | Cote d'Ivoire | $2.3M | ⚠ Locked |
| NATIONAL EMERGENCY RES… | South Africa | $2.1M | 2 sup. |
| UNITED NATIONS DEVELOP… | Venezuela | $1.0M | ⚠ Locked |
| BUREAU DU PNUD UNDP IN… | Republic of the Congo | $367K | ⚠ Locked |
| NATIONAL COUNCIL FOR T… | Burkina Faso | $146K | ⚠ Locked |
| MEDICAL SUPPLIES DIVIS… | Sri Lanka | $139K | ⚠ Locked |
| MINISTRY OF HEALTH (CH… | Laos | $98K | ⚠ Locked |
| CIPS MINISTERIO DE SA | Nicaragua | $89K | ⚠ Locked |
| MEDPRO PHARMACEUTICA P… | South Africa | $54K | ⚠ Locked |
#2
EXPORTER PROFILE #2 OF 6 — TRADE FLOW MAP
CIPLA LTD — Supplier → Country → Importer
5 destination countries, top 5 importers per country
Fig 5.P2.3 Zimbabwe absorbs $2.8M — the thickest ribbon.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 5 destinations and up to 2 importers per destination.
#3
EXPORTER PROFILE #3 OF 6
EMCURE PHARMACEUTICALS LTD
Pune-Maharashtra · India’s #3 dolutegravir supplier by USD · 2025-Q4
2025-Q4 USD
$6.1M
16.2% market share
SHIPMENTS
19
avg $321K/ship
COUNTRIES
8
destination markets
BUYERS
9
7 single-sourced
BRANDED
89%
of shipments
DOSAGE FORMS
1
product types
TOP 8 DESTINATIONS
South Africa is the #1 market at $3.2M (53% of trade), followed by Lesotho at $1.6M. 8 countries served.
| # | Country | USD | Ships | Share |
|---|---|---|---|---|
| 1 | South Africa | $3.2M | 7 | 53.1% |
| 2 | Lesotho | $1.6M | 3 | 27.1% |
| 3 | Namibia | $551K | 3 | 9.0% |
| 4 | Bolivia | $519K | 1 | 8.5% |
| 5 | Zimbabwe | $122K | 1 | 2.0% |
| 6 | Angola | $13K | 1 | 0.2% |
| 7 | Cambodia | $6K | 2 | 0.1% |
| 8 | Mauritius | $133 | 1 | 0.0% |
MONTHLY TREND
Dec was the strongest month, ending the quarter on a high at $4.3M.
PRODUCT MIX
Tablet dominates at 100% of trade.
TOP BUYERS · 7/9 LOCKED IN
7 of 9 buyers source exclusively from this supplier — high lock-in with low competitive threat.
| Buyer | Country | USD | Status |
|---|---|---|---|
| NATIONAL DRUGS SERVICE… | Lesotho | $1.6M | ⚠ Locked |
| EMCURE PHARMACEUTICALS… | South Africa | $1.6M | ⚠ Locked |
| NATIONAL EMERGENCY RES… | South Africa | $1.6M | 2 sup. |
| THE MINISTRY OF HEALTH… | Namibia | $551K | ⚠ Locked |
| PROGRAMA DE LAS NACION… | Bolivia | $519K | 2 sup. |
| MINISTRY OF HEALTH AND… | Zimbabwe | $122K | ⚠ Locked |
| UNDP/GLOBAL FUND PROJECT | Angola | $13K | ⚠ Locked |
| NATIONAL CENTER FOR HI… | Cambodia | $6K | ⚠ Locked |
| THE MAURITIUS PHARMACY… | Mauritius | $133 | ⚠ Locked |
#3
EXPORTER PROFILE #3 OF 6 — TRADE FLOW MAP
EMCURE PHARMACEUTICALS LTD — Supplier → Country → Importer
5 destination countries, top 5 importers per country
Fig 5.P3.3 South Africa absorbs $3.2M — the thickest ribbon.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 5 destinations and up to 2 importers per destination.
#4
EXPORTER PROFILE #4 OF 6
SUN PHARMACEUTICAL INDUSTRIES LTD
Mumbai · India’s #4 dolutegravir supplier by USD · 2025-Q4
2025-Q4 USD
$2.8M
7.6% market share
SHIPMENTS
6
avg $474K/ship
COUNTRIES
4
destination markets
BUYERS
5
3 single-sourced
BRANDED
33%
of shipments
DOSAGE FORMS
1
product types
TOP 4 DESTINATIONS
Mozambique is the #1 market at $2.2M (77% of trade), followed by Malaysia at $381K. 4 countries served.
| # | Country | USD | Ships | Share |
|---|---|---|---|---|
| 1 | Mozambique | $2.2M | 1 | 77.5% |
| 2 | Malaysia | $381K | 2 | 13.4% |
| 3 | Russia | $258K | 2 | 9.1% |
| 4 | Azerbaijan | $608 | 1 | 0.0% |
MONTHLY TREND
Oct peaked at $2.2M. Dec was the weakest at $10K.
PRODUCT MIX
Tablet dominates at 100% of trade.
TOP BUYERS · 3/4 LOCKED IN
3 of 4 buyers source exclusively from this supplier — high lock-in with low competitive threat.
| Buyer | Country | USD | Status |
|---|---|---|---|
| MINISTERIO DA SA | Mozambique | $2.2M | ⚠ Locked |
| AO RANBAXY | Russia | $258K | ⚠ Locked |
| RANBAXY (MALAYSIA) SDN… | Malaysia | $190K | ⚠ Locked |
| Undisclosed buyer | Malaysia | $190K | N/A |
| MINISTRY OF HEALTH OF … | Azerbaijan | $608 | 2 sup. |
#4
EXPORTER PROFILE #4 OF 6 — TRADE FLOW MAP
SUN PHARMACEUTICAL INDUSTRIES LTD — Supplier → Country → Importer
4 destination countries, top 5 importers per country
Fig 5.P4.3 Mozambique absorbs $2.2M — the thickest ribbon.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 4 destinations and up to 2 importers per destination.
#7
EXPORTER PROFILE #5 OF 6
MACLEODS PHARMACEUTICALS LTD
Mumbai Maharashtra · India’s #7 dolutegravir supplier by USD · 2025-Q4
2025-Q4 USD
$70K
0.2% market share
SHIPMENTS
18
avg $4K/ship
COUNTRIES
11
destination markets
BUYERS
12
11 single-sourced
BRANDED
22%
of shipments
DOSAGE FORMS
2
product types
TOP 10 DESTINATIONS
South Sudan is the #1 market at $41K (59% of trade), followed by Angola at $10K. 11 countries served.
| # | Country | USD | Ships | Share |
|---|---|---|---|---|
| 1 | South Sudan | $41K | 1 | 59.0% |
| 2 | Angola | $10K | 4 | 14.1% |
| 3 | Guyana | $9K | 3 | 12.3% |
| 4 | Thailand | $4K | 2 | 6.4% |
| 5 | Tanzania | $3K | 1 | 4.1% |
| 6 | Nicaragua | $2K | 2 | 3.3% |
| 7 | Republic of the Congo | $431 | 1 | 0.6% |
| 8 | United Arab Emirates | $48 | 1 | 0.1% |
| 9 | Haiti | $34 | 1 | 0.0% |
| 10 | Honduras | $0 | 1 | 0.0% |
MONTHLY TREND
Dec was the strongest month, ending the quarter on a high at $60K.
PRODUCT MIX
Dispersible Tablet dominates at 79% of trade. Tablet (21.4%) and others are secondary formulations.
TOP BUYERS · 11/11 LOCKED IN
11 of 11 buyers source exclusively from this supplier — high lock-in with low competitive threat.
| Buyer | Country | USD | Status |
|---|---|---|---|
| UNDP SOUTH SUDAN | South Sudan | $41K | ⚠ Locked |
| INTERMED ANGOLA, LDA | Angola | $10K | ⚠ Locked |
| NEW GPC INC | Guyana | $9K | ⚠ Locked |
| US EMBASSY (C) | Tanzania | $3K | ⚠ Locked |
| CIPS - MINISTERIO DE SA | Nicaragua | $2K | ⚠ Locked |
| M.S. TERMINAL CO LTD | Thailand | $2K | ⚠ Locked |
| Undisclosed buyer | Thailand | $2K | N/A |
| PROGRAMME DES NATIONS … | Republic of the Congo | $431 | ⚠ Locked |
| IDA TRADING MEA | United Arab Emirates | $48 | ⚠ Locked |
| WORLD VISION INTERNATI… | Haiti | $34 | ⚠ Locked |
#7
EXPORTER PROFILE #5 OF 6 — TRADE FLOW MAP
MACLEODS PHARMACEUTICALS LTD — Supplier → Country → Importer
5 destination countries, top 5 importers per country
Fig 5.P5.3 South Sudan absorbs $41K — the thickest ribbon.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 5 destinations and up to 2 importers per destination.
#8
EXPORTER PROFILE #6 OF 6
HEET HEALTHCARE PVT LTD
Ahmedabad · India’s #8 dolutegravir supplier by USD · 2025-Q4
2025-Q4 USD
$31K
0.1% market share
SHIPMENTS
12
avg $3K/ship
COUNTRIES
2
destination markets
BUYERS
2
unique importers
BRANDED
0%
of shipments
DOSAGE FORMS
0
product types
TOP 2 DESTINATIONS
Singapore is the #1 market at $31K (99% of trade), followed by Poland at $200. 2 countries served.
| # | Country | USD | Ships | Share |
|---|---|---|---|---|
| 1 | Singapore | $31K | 10 | 99.4% |
| 2 | Poland | $200 | 2 | 0.6% |
MONTHLY TREND
Dec was the strongest month, ending the quarter on a high at $16K.
PRODUCT MIX
Unknown dominates at 100% of trade.
TOP BUYERS · 0 BUYERS
Buyers are well-diversified across multiple Indian suppliers.
| Buyer | Country | USD | Status |
|---|---|---|---|
| Undisclosed buyer | Singapore | $24K | N/A |
| Undisclosed buyer | Singapore | $8K | N/A |
#8
EXPORTER PROFILE #6 OF 6 — TRADE FLOW MAP
HEET HEALTHCARE PVT LTD — Supplier → Country → Importer
2 destination countries, top 5 importers per country
Fig 5.P6.3 Singapore absorbs $31K — the thickest ribbon.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 2 destinations and up to 2 importers per destination.
06
PART III — WHO’S IN THIS MARKET
Global Buyer Rankings & Intelligence
55 importers across 47 countries — who is buying Indian dolutegravir and how much
KEY TAKEAWAY
The demand side is dramatically more fragmented than supply: the top 25 importers together hold only 63.2% of total USD. 89% of buyers source from a single Indian supplier — a vast pool of lock-in candidates.
S FOR SUPPLIERS
Find the importers buying from your competitors. The rankings reveal who has volume, who pays well, and who sources from multiple Indian suppliers (potential pitch targets).
B FOR BUYERS
See where you rank among global importers of Indian dolutegravir. Compare your USD and shipment count against peers in your country and dosage segment.
Fig 6.1 NATIONAL EMERGENCY RESPONSE COUNCIL is the #1 importer at $3.7M (9.7%) — top 25 by trade value
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one global importer ranked by USD.
Fig 6.2 Re-ranked by shipment count — compare with Fig 6.1 for divergences
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Same 25 importers re-ranked by shipment count.
§6.1 Sourcing diversity — how many Indian suppliers does each buyer use?
89%
Single-source
49 buyers rely on exactly 1 Indian supplier
7%
Dual-source
4 buyers use 2 Indian suppliers
0%
Multi-source (3–4)
0 buyers diversified across 3–4
4%
Broad-source (5+)
2 buyers with 5+ Indian suppliers
06
PART III — WHO’S IN THIS MARKET
Single-Source Buyers & Price Benchmark
Lock-in opportunities grouped by country + where each buyer sits on the price spectrum
KEY TAKEAWAY
These importers source dolutegravir from exactly one Indian supplier. For each one, the table shows the incumbent, price, and dosage.
S FOR SUPPLIERS
This is your target list. Each row is a buyer locked into one competitor. Offer 5–10% better pricing to win the second-source slot.
B FOR BUYERS
If you see your company here, you are fully dependent on one Indian supplier. Consider qualifying a second source.
§6.2 Single-source lock-in by country
South Africa 2 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| EMCURE PHARMACEUTICALS… | EMCURE PHARMACEUTICA… | $1.6M | $7.619 | Tablet |
| MEDPRO PHARMACEUTICA P… | CIPLA LTD | $54K | $0.173 | Tablet |
Namibia 2 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| THE MINISTRY OF HEALTH… | EMCURE PHARMACEUTICA… | $551K | $2.975 | Tablet |
| COSPHARM | HETERO LABS LTD | $20K | $0.238 | Tablet |
Republic of the Congo 2 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| BUREAU DU PNUD UNDP IN… | CIPLA LTD | $367K | $0.084 | Tablet |
| PROGRAMME DES NATIONS … | MACLEODS PHARMACEUTI… | $431.293 | $0.0005 | Tablet |
Malaysia 2 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| RANBAXY (MALAYSIA) SDN… | SUN PHARMACEUTICAL I… | $190K | $1.263 | Tablet |
| NSK FORWARDING & TRANS… | PINKLINE EXPORTS | $3K | $7.793 | — |
Sri Lanka 2 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| MEDICAL SUPPLIES DIVIS… | CIPLA LTD | $139K | $0.090 | Tablet |
| THE ESSES PHARMACY (PV… | PLEASANT EXPORTS | $455.592 | $22.780 | Tablet |
§6.3 Price positioning — top 25 importers
| # | Importer | Country | USD | $/ship | Tier |
|---|---|---|---|---|---|
| 1 | NATIONAL EMERGENCY R… | South Africa | $3.7M | $146K | Premium |
| 2 | MINISTRY OF HEALTH A… | Zimbabwe | $2.8M | $84K | Premium |
| 3 | PROGRAMME NATIONAL D… | Cote d'Ivoire | $2.3M | $87K | Premium |
| 4 | MINISTERIO DA SA | Mozambique | $2.2M | $2.2M | Premium |
| 5 | THE MISSION DIRECTOR | Nigeria | $1.8M | $204K | Premium |
| 6 | OFFICE PHARMACEUTIQU… | Gabon | $1.7M | $340K | Premium |
| 7 | NATIONAL DRUGS SERVI… | Lesotho | $1.6M | $550K | Premium |
| 8 | EMCURE PHARMACEUTICA… | South Africa | $1.6M | $327K | Premium |
| 9 | MINISTRY OF HEALTH O… | Tanzania | $1.4M | $677K | Premium |
| 10 | UNITED NATIONS DEVEL… | Venezuela | $1.0M | $67K | Premium |
| 11 | HOANG DUC PHARMACEUT… | Vietnam | $606K | $121K | Premium |
| 12 | THE MINISTRY OF HEAL… | Namibia | $551K | $184K | Premium |
| 13 | PROGRAMA DE LAS NACI… | Bolivia | $533K | $178K | Premium |
| 14 | BUREAU DU PNUD UNDP … | Republic of the Congo | $367K | $73K | Premium |
| 15 | AO RANBAXY | Russia | $258K | $129K | Premium |
| 16 | SEVEN PHARMA CHILE SPA | Chile | $204K | $204K | Premium |
| 17 | RANBAXY (MALAYSIA) S… | Malaysia | $190K | $190K | Premium |
| 18 | SECRETARIAT EXECUTIF… | Mauritania | $149K | $30K | Mid |
| 19 | NATIONAL COUNCIL FOR… | Burkina Faso | $146K | $73K | Premium |
| 20 | MEDICAL SUPPLIES DIV… | Sri Lanka | $139K | $69K | Premium |
| 21 | MINISTRY OF HEALTH A… | Zimbabwe | $122K | $122K | Premium |
| 22 | MINISTRY OF HEALTH (… | Laos | $98K | $98K | Premium |
| 23 | CIPS MINISTERIO DE SA | Nicaragua | $89K | $45K | Premium |
| 24 | BROWN & BURK PHILIPP… | Philippines | $87K | $87K | Premium |
| 25 | UNDP | DR Congo | $64K | $64K | Premium |
06
PART III — WHO’S IN THIS MARKET
Market Relationship Map
The top 18 × 20 supplier ↔ buyer network as a circular flow diagram
Fig 6.3 HETERO LABS LTD → NATIONAL EMERGENCY RESPONSE COUNCIL is the strongest relationship.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left semicircle = top 18 Indian suppliers; right = top 20 global buyers. Arc length = total USD; colored ribbons = individual relationships, thickness = USD value. Insight: follow the thickest ribbons to identify the dominant trading pairs.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
How Indian dolutegravir prices vary by supplier, country and dosage form
KEY TAKEAWAY
Dolutegravir prices span 147252× ($0.0005 → $69.88). The coefficient of variation is 2.95. Dosage form, not destination, is the primary price driver.
S FOR SUPPLIERS
Use the box plot to see where your product sits on the price spectrum. The tornado chart shows exactly where you sit relative to the market median.
B FOR BUYERS
Use this section to benchmark the price you pay against the market. The percentile strip tells you if your current supplier is charging you premium, mid-market or budget rates.
§7.1 Price distribution · Table 7.1
| Statistic | Value | Interpretation |
|---|---|---|
| Min | $0.0005 | Lowest observed unit price |
| P5 | $0.0048 | 5th percentile |
| P25 | $0.083 | 25th percentile (Q1) |
| Median | $0.087 | 50th percentile (Q2) |
| P75 | $0.173 | 75th percentile (Q3) |
| P95 | $20.67 | 95th percentile |
| Max | $69.88 | Highest observed unit price |
| Mean | $4.15 | Arithmetic average |
| CV | 295% | Coefficient of variation (std/mean) |
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
Fig 7.1 HEET HEALTHCARE PVT LTD prices at $45.24/unit vs market median $0.087.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar shows one supplier’s average unit price relative to the market median (dashed line). Red = above median (premium), green = below (budget).
COMMODITY KINGS
high volume · low unit price
Bulk API/tablet. Largest absolute USD despite lowest per-unit prices. e.g. HETERO LABS LTD Sourcing: best for cost-driven procurement.
BULK LEADERS
high volume · premium price
Branded-generic leaders, above-median pricing. e.g. M D PHARMACY Sourcing: hardest to displace; compete on relationship.
LONG-TAIL
low volume · low unit price
Spot/opportunistic players. e.g. GNH INDIA PHARMACEUTICALS Sourcing: first to approach for new tenders.
PREMIUM NICHE
low volume · premium price
Sterile injectables and infusions. Hospital-grade. e.g. APPLE PHARMACEUTICALS Sourcing: expect 10× price vs tablet.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
Outlier forensics and the procurement cheat sheet — what to expect to pay by country × dosage
KEY TAKEAWAY
Extreme prices are real: the highest are specialty/sterile formulations; the lowest are bulk API. The cheat sheet matrix is the take-home reference for procurement teams.
§7.2 Outlier forensics — top 10 highest and 10 lowest unit prices
↑ TOP 10 HIGHEST USD/UNIT
| Date | Exporter | Country | Dosage | Qty | USD | $/unit | Why |
|---|---|---|---|---|---|---|---|
| Nov 2025 | MICRO LABS LTD | Zimbabwe | Tablet | 348 | $42K | $119.90 | Specialty / small-batch |
| Nov 2025 | HEET HEALTHCARE … | Singapore | — | 60 | $4K | $69.88 | Specialty / small-batch |
| Nov 2025 | HEET HEALTHCARE … | Singapore | — | 60 | $4K | $69.88 | Specialty / small-batch |
| Nov 2025 | HEET HEALTHCARE … | Singapore | — | 42 | $3K | $69.88 | Specialty / small-batch |
| Nov 2025 | HEET HEALTHCARE … | Singapore | — | 42 | $3K | $69.88 | Specialty / small-batch |
| Nov 2025 | HEET HEALTHCARE … | Singapore | — | 6 | $419.28 | $69.88 | Specialty / small-batch |
| Nov 2025 | HEET HEALTHCARE … | Singapore | — | 6 | $419.28 | $69.88 | Specialty / small-batch |
| Dec 2025 | BRINTON PHARMACE… | Vanuatu | Tablet | 20 | $744.97 | $37.25 | Specialty / small-batch |
| Nov 2025 | HOPEWELL SOLUTIONS | United Arab Emirates | Tablet | 200 | $6K | $32.35 | Specialty / small-batch |
| Dec 2025 | HEET HEALTHCARE … | Singapore | — | 149 | $4K | $25.51 | Specialty / small-batch |
↓ TOP 10 LOWEST USD/UNIT
| Date | Exporter | Country | Dosage | Qty | USD | $/unit | Why |
|---|---|---|---|---|---|---|---|
| Dec 2025 | CIPLA LTD | Uzbekistan | Tablet | 981K | $1K | $0.0010 | Bulk generic tablet |
| Dec 2025 | CIPLA LTD | Uzbekistan | Tablet | 1.2M | $1K | $0.0010 | Bulk generic tablet |
| Dec 2025 | CIPLA LTD | Uzbekistan | Tablet | 176K | $181.49 | $0.0010 | Bulk generic tablet |
| Dec 2025 | HETERO LABS LTD | Mauritania | Tablet | 91K | $96.44 | $0.0011 | Bulk generic tablet |
| Dec 2025 | HETERO LABS LTD | Mauritania | Tablet | 91K | $97.13 | $0.0011 | Bulk generic tablet |
| Dec 2025 | SUN PHARMACEUTIC… | Azerbaijan | Tablet | 101K | $607.93 | $0.0060 | Bulk generic tablet |
| Nov 2025 | HETERO LABS LTD | Honduras | Tablet | 132K | $3K | $0.026 | |
| Oct 2025 | HETERO LABS LTD | Mauritius | Tablet | 20K | $545.42 | $0.027 | |
| Oct 2025 | MACLEODS PHARMAC… | Nicaragua | Tablet | 65K | $2K | $0.029 | |
| Oct 2025 | HETERO LABS LTD | Bolivia | Tablet | 187K | $7K | $0.035 |
§7.3 Procurement cheat sheet — median USD/unit by country × dosage
Fig 7.2 Median unit price by country × dosage form — darker cells = higher prices.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each cell shows the median price per unit for that country-dosage combination. Dark blue = expensive, light = cheap. Blank cells = no shipments in that combination.
NEGOTIATION RANGE
Use each cell value as the anchor price. Typical dynamics:
- Budget buyer: anchor − 10–15% (floor = cost + freight)
- Mid-market: anchor ± 5–10%
- Premium/tender: anchor + 10–25% (regulated, quality premium)
- Injection/infusion: always 4–10× the tablet price
KEY TAKEAWAYS
- Dosage form is the #1 price driver, not destination
- Light cells = easy-entry markets for small suppliers
- Dark cells = premium markets requiring regulatory investment
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Which Indian ports ship dolutegravir, which global ports receive it, and which corridors are high-value vs bulk
KEY TAKEAWAY
Dolutegravir leaves India through 10+ ports. The top 5 (NHAVA SHEVA SEA (JNPT), AHMEDABAD AIR, DADRI ICD) handle 95.1% of total USD. SEA moves 61% of shipments.
S FOR SUPPLIERS
Use the dumbbell to classify your port as high-value hub or bulk workhorse. Note the short-sea routes — Bangladesh, Sri Lanka, Myanmar and East Africa are the easiest logistics corridors for first-time exporters.
B FOR BUYERS
Use the destination port ranking to find which Indian ports serve your market. The lead-time estimates tell you what transit time to expect.
Fig 8.1 NHAVA SHEVA SEA (JNPT) handles $27.6M — top 10 Indian origin ports by trade value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one Indian port. Bar length = USD value. The largest ports handle the majority of trade.
Fig 8.2 Durban is the #1 global destination port — top 25 by USD value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one destination port worldwide. Bar length = USD value received from India.
§8.1 Reference transit times for key India → global corridors
| Route | Mode | Transit time | Notes |
|---|---|---|---|
| NHAVA SHEVA SEA (JNPT) → US East Coast | Sea | 22–28 days | Via Suez; 2–3 transshipments typical |
| NHAVA SHEVA SEA (JNPT) → Lagos (Nigeria) | Sea | 18–24 days | Direct liner service available |
| MUMBAI AIR (SAHAR) → New York JFK | Air | 3–5 days | Direct cargo; cold-chain available |
| MUNDRA SEA → Rotterdam | Sea | 20–26 days | Via Suez; Hamburg also served |
| HYDERABAD AIR → London Heathrow | Air | 2–4 days | Pharma-grade cargo corridor |
| CHENNAI SEA → Chittagong (Bangladesh) | Sea | 7–12 days | Short-sea route; high frequency |
| RAXAUL → Birgunj (Nepal) | Road | 1–2 days | Land border crossing |
| NHAVA SHEVA SEA (JNPT) → Mombasa (Kenya) | Sea | 14–20 days | Direct or via Colombo hub |
Table 8.1 — Reference times based on standard shipping corridors. Air = 2–5 days; sea = 7–28 days; road = 1–2 days. Add 3–7 days for customs clearance at destination.
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Trade corridors — origin port to mode of transport to destination region
KEY TAKEAWAY
SEA dominates at 61% of shipments. The alluvial traces every dollar from Indian origin port through transport mode to destination region.
SEA
$28.0M
74.6% of USD · 61.0% of ships
AIR
$6.8M
18.0% of USD · 36.5% of ships
ICD
$2.8M
7.5% of USD · 2.5% of ships
Fig 8.3 The dominant corridor is NHAVA SHEVA SEA (JNPT) → Sea → Africa ($25.7M).
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian origin ports. Middle = transport mode. Right = destination region. Ribbon thickness = USD value; color = mode. Follow the thickest ribbons to find the highest-value corridors.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market concentration, supply-chain risk, and the dependency patterns that signal where to act
KEY TAKEAWAY
Cote d'Ivoire is the most concentrated destination (HHI 10000, 1 suppliers). South Africa is the most competitive (HHI 3971).
S FOR SUPPLIERS
The HHI barbell shows where competitors have locked up a market (concentrated = poaching opportunity) vs where you must compete on quality (fragmented). The slope chart reveals who is gaining ground.
B FOR BUYERS
The HHI barbell tells you whether your country has enough supplier options. If concentrated (red zone), you have fewer alternatives.
Fig 9.1 Cote d'Ivoire (HHI 10,000) is the most concentrated — South Africa (HHI 3,971) is the most competitive.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
What is HHI? The Herfindahl-Hirschman Index measures how concentrated a market is among its suppliers. It ranges from 0 to 10,000. Below 1,500 (green zone) = many suppliers compete openly — healthy, competitive market with low risk. 1,500–2,500 (yellow zone) = a few suppliers hold significant share — moderate concentration. Above 2,500 (red zone) = one or two suppliers dominate the market — high risk for buyers who may lose supply, and hard to break into for new suppliers. Conclusion: 20 of 20 destination markets are concentrated (red zone). 0 are competitive (green zone). Buyers in red-zone markets should urgently qualify a second Indian supplier to reduce dependency risk.
§9.1 Single-source dependencies
| Buyer | Country | Sole supplier | USD | Ships | Risk |
|---|---|---|---|---|---|
| PROGRAMME NATIONAL D… | Cote d'Ivoire | CIPLA LTD | $2.3M | 27 | CRITICAL |
| MINISTERIO DA SA | Mozambique | SUN PHARMACEUTIC… | $2.2M | 1 | CRITICAL |
| THE MISSION DIRECTOR | Nigeria | HETERO LABS LTD | $1.8M | 9 | CRITICAL |
| OFFICE PHARMACEUTIQU… | Gabon | M D PHARMACY | $1.7M | 5 | CRITICAL |
| NATIONAL DRUGS SERVI… | Lesotho | EMCURE PHARMACEU… | $1.6M | 3 | CRITICAL |
| EMCURE PHARMACEUTICA… | South Africa | EMCURE PHARMACEU… | $1.6M | 5 | CRITICAL |
| UNITED NATIONS DEVEL… | Venezuela | CIPLA LTD | $1.0M | 15 | CRITICAL |
| HOANG DUC PHARMACEUT… | Vietnam | HETERO LABS LTD | $606K | 5 | CRITICAL |
Conclusion: 49 buyers depend on exactly one Indian supplier, representing $15.7M in trade. 9 are rated CRITICAL — if their sole supplier fails, they have no backup. For suppliers: each row is a competitor’s locked-in customer you can target.
§9.2 Multi-source resilience
| Buyer | Country | Suppliers | USD | Dominant | Resilience |
|---|
Conclusion: 0 of these buyers have HIGH resilience (3+ active suppliers). These are the hardest accounts to win but safest partners for long-term contracts.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market entry playbook and risk landscape by destination country
KEY TAKEAWAY
15 target markets with specific entry approaches. Large suppliers: focus on regulated Tier 1 markets. Small/mid-size: start with Tier 2–3 (low barrier, growing demand).
§9.3 Sourcing recommendations · Table 9.1
| Country | Tier | Lead | Price | Risk | Entry approach |
|---|---|---|---|---|---|
| South Africa | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Tanzania | Tier 3 (emerging) | 3–5 days (air) | $0.01–$0.10/unit | LOW | First-mover advantage |
| Zimbabwe | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Kenya | Tier 3 (emerging) | 14–28 days (sea) | $0.01–$0.10/unit | LOW | First-mover advantage |
| Cote d'Ivoire | Tier 3 (emerging) | 14–28 days (sea) | $0.01–$0.10/unit | LOW | First-mover advantage |
| Mozambique | Tier 3 (emerging) | 14–28 days (sea) | $0.01–$0.10/unit | LOW | First-mover advantage |
| Gabon | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Nigeria | Tier 3 (emerging) | 3–5 days (air) | $0.10–$1/unit | LOW | First-mover advantage |
| Lesotho | Tier 3 (emerging) | 14–28 days (sea) | $1–$10/unit | LOW | First-mover advantage |
| Venezuela | Tier 3 (emerging) | 14–28 days (sea) | $0.01–$0.10/unit | LOW | First-mover advantage |
| DR Congo | Tier 3 (emerging) | 3–5 days (air) | $0.01–$0.10/unit | LOW | First-mover advantage |
| Vietnam | Tier 3 (emerging) | 14–28 days (sea) | $0.01–$0.10/unit | LOW | First-mover advantage |
| Namibia | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Bolivia | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Malaysia | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
For suppliers: Tier 1 markets (US, UK, France) require regulatory investment but offer premium pricing. Tier 3 markets (emerging) have low barriers — ideal for first-time exporters. For buyers: Use the price band and lead time to benchmark your current supplier’s terms.
Fig 9.2 0 markets in the Growth Opportunity zone (competitive + growing). 11 in Fragile Dependency (concentrated + shrinking).
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bubble = one destination. X-axis = HHI (concentration). Y-axis = growth %. Bubble size = USD. Green zone (top-left) = Growth Opportunity — competitive markets that are growing, best for new entrants. Red zone (bottom-right) = Fragile Dependency — concentrated + shrinking, high supply-chain risk. Conclusion: Key markets are the top growth opportunities.
09
PART V — ACTION
Action Plan & Easy-Entry Markets
12 prioritised actions + 15 low-competition destination countries for small & mid-size suppliers
KEY TAKEAWAY
Quick Wins: execute this quarter. Big Bets: plan for next 6–12 months. Plus 15 countries with ≤5 Indian suppliers — the best entry points for SMEs.
S
FOR SUPPLIERS
| ID | Action | Timing | Impact |
|---|---|---|---|
| A1 | Pitch top single-source buyer in Cote d'Ivoire | This Q | HIGH |
| A2 | Offer alternative to top multi-source buyer | This Q | HIGH |
| A3 | Audit Cote d'Ivoire lock-ins (HHI 10000) | This Q | MED |
| A5 | Enter South Africa (4 suppliers) | This Q | HIGH |
| A6 | Enter Zimbabwe (3 suppliers) | This Q | MED |
| A8 | Build Tanzania distribution | 6–12m | HIGH |
| A9 | Bundle injection/infusion catalog for premium markets | 6–12m | MED |
B
FOR BUYERS
| ID | Action | Timing | Impact |
|---|---|---|---|
| A4 | Monitor rising exporters (CIPLA LTD) | This Q | MED |
| A7 | Register for South Africa tenders | 6–12m | HIGH |
| A10 | Track quarterly HHI shifts across key destinations | This Q | LOW |
| A11 | Map competitor buyer portfolios quarterly | This Q | MED |
| A12 | Qualify second source for single-source buyers | This Q | MED |
§9.4 Easy-entry markets — 15 countries with ≤5 Indian suppliers
| # | Country | Region | Suppliers | Q4 USD | Growth | Barrier | Why this is easy |
|---|---|---|---|---|---|---|---|
| 1 | South Africa | Africa | 4 | $11.4M | +596.5% | LOW | Growing 597% with only 4 competitors |
| 2 | Zimbabwe | Africa | 3 | $2.9M | +2168.1% | LOW | Growing 2168% with only 3 competitors |
| 3 | Bolivia | Other | 2 | $533K | +3826.1% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 4 | Namibia | Africa | 2 | $570K | +2700.6% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 5 | Tanzania | Africa | 2 | $4.8M | -100% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 6 | Kenya | Africa | 1 | $2.4M | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 7 | Cote d'Ivoire | Africa | 1 | $2.3M | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 8 | Mozambique | Africa | 1 | $2.2M | -100% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 9 | Gabon | Africa | 1 | $2.2M | -100% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 10 | Nigeria | Africa | 1 | $1.8M | -100% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 11 | Lesotho | Africa | 1 | $1.6M | -100% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 12 | Venezuela | Other | 1 | $1.0M | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 13 | Singapore | Asia | 2 | $32K | +2443.8% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 14 | DR Congo | Africa | 1 | $702K | -100% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 15 | Vietnam | Asia | 1 | $606K | -100% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
This report covers 241 2025-Q4 Dolutegravir shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/dolutegravir
10
PART VI — EVIDENCE REGISTER
Comprehensive Shipment Records by Region
Authoritative source behind all analytics in this report — every shipment appears exactly once
KEY TAKEAWAY
This section contains every one of the 241 2025-Q4 dolutegravir shipments, organised by Region → Exporter → Shipment rows. No row is duplicated.
S FOR SUPPLIERS
Jump to any destination country to see exactly who your competitors ship to, what they charge, through which port, and how often.
B FOR BUYERS
Jump to your country to see every Indian dolutegravir shipment that arrived in 2025-Q4: supplier, price, dosage, port.
§10.1 Global totals
SHIPMENTS
241
across all regions
TOTAL USD
$37.59M
2025-Q4 FOB value
UNITS
311.4M
tablets, capsules, etc.
SUPPLIERS
18
Indian exporters
BUYERS
55
global importers
COUNTRIES
47
destinations
§10.2 Regional breakdown
§10.3 Key insights from the data
Africa is the largest region at $34.07M (90.6%), spanning 19 countries.
18 Indian suppliers shipped to 55 buyers across 47 countries — average shipment value $156K.
Top 0 markets: .
Every row below is real customs data — date, importer, dosage, brand, quantity, unit price, total USD, origin port, destination port, and transport mode.
§10.4 How to read a country page
1
6 KPI cards — shipments, USD, qty, exporters, importers, avg unit price.
2
4 mini-lists — top exporters, importers, dosages, monthly trend.
3
Shipment register — every row grouped by exporter. No row is duplicated or omitted.
10
PART VI — DRILL-DOWN · AFRICA
Region: Africa
19 countries · 155 shipments · $34.07M · 8 Indian suppliers · 29 buyers
SHIPMENTS
155
USD
$34.07M
COUNTRIES
19
SUPPLIERS
8
BUYERS
29
HHI
3,150
concentrated
Top 19 destination countries in Africa
1
South Africa (33.5%)
$11.42M
2
Tanzania (14.2%)
$4.83M
3
Zimbabwe (8.6%)
$2.92M
4
Kenya (7.0%)
$2.38M
5
Cote d'Ivoire (6.9%)
$2.34M
6
Mozambique (6.5%)
$2.20M
7
Gabon (6.4%)
$2.18M
8
Nigeria (5.4%)
$1.84M
9
Lesotho (4.8%)
$1.65M
10
DR Congo (2.1%)
$702K
11
Namibia (1.7%)
$570K
12
Republic of the Congo (1.1%)
$368K
13
Botswana (0.9%)
$297K
14
Mauritania (0.4%)
$149K
15
Burkina Faso (0.4%)
$146K
16
South Sudan (0.1%)
$41K
17
Angola (0.1%)
$23K
18
Mauritius (0.0%)
$678.16
19
Madagascar (0.0%)
$14.61
Top 8 Indian suppliers into Africa
1
HETERO LABS LTD
$16.29M
2
CIPLA LTD
$7.72M
3
EMCURE PHARMACEUTICALS LTD
$5.57M
4
SUN PHARMACEUTICAL INDUSTRIES LTD
$2.20M
5
M D PHARMACY
$2.18M
6
MACLEODS PHARMACEUTICALS LTD
$54K
7
MICRO LABS LTD
$44K
8
SHARVIK IMPEX (INDIA) PVT LTD
$14.61
Top 27 Africa importers
1
NATIONAL EMERGENCY RESPONSE COUNCIL · South Africa
$3.66M
2
MINISTRY OF HEALTH AND CHILD CARE · Zimbabwe
$2.76M
3
PROGRAMME NATIONAL DE LUTTE CONTRE · Cote d'Ivoire
$2.34M
4
MINISTERIO DA SA · Mozambique
$2.20M
5
THE MISSION DIRECTOR · Nigeria
$1.84M
6
OFFICE PHARMACEUTIQUE NATIONAL (OPN · Gabon
$1.70M
7
NATIONAL DRUGS SERVICE ORGANIZATION · Lesotho
$1.65M
8
EMCURE PHARMACEUTICALS SA (PTY) LTD · South Africa
$1.63M
9
MINISTRY OF HEALTH OF THE · Tanzania
$1.35M
10
THE MINISTRY OF HEALTH AND SOCIAL S · Namibia
$551K
11
BUREAU DU PNUD UNDP IN CONGOCROISEM · Republic of the Congo
$367K
12
SECRETARIAT EXECUTIF NATIONAL DE · Mauritania
$149K
13
NATIONAL COUNCIL FOR THE STRUGGLEAG · Burkina Faso
$146K
14
MINISTRY OF HEALTH AND CHILD CAREC/ · Zimbabwe
$122K
15
UNDP · DR Congo
$64K
16
MEDPRO PHARMACEUTICA PTY LTD · South Africa
$54K
17
MINISTRY OF HEALTH & CHILD CARE · Zimbabwe
$42K
18
UNDP SOUTH SUDAN · South Sudan
$41K
19
COSPHARM · Namibia
$20K
20
UNDP/GLOBAL FUND PROJECT · Angola
$13K
21
INTERMED ANGOLA, LDA · Angola
$10K
22
US EMBASSY (C) · Tanzania
$3K
23
TRIDENT HEALTHCARE LTD · Mauritius
$545.42
24
PROGRAMME DES NATIONS UNIES POUR LE · Republic of the Congo
$431.29
25
THE MAURITIUS PHARMACY (SEEGOBIN) L · Mauritius
$132.74
26
P.F.ASSELBERGS · Madagascar
$14.61
27
US EMBASSY MBABANE · South Africa
$0.0000
Top 4 dosage forms
1
Tablet
$27.99M
2
Unknown
$5.89M
3
disopr
$149K
4
Dispersible Tablet
$44K
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 32 | $12.06M | $377K |
| Nov | 16 | $10.40M | $650K |
| Dec | 107 | $11.61M | $108K |
Shipment register · 155 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — HETERO LABS LTD · 30 shipments · $16.29M | |||||||||||
| 1 | Oct 2025 | COSPHARM | Namibia | Tablet | 82.5K | TBS | $0.238 | $20K | HYDERABAD AIR | WINDHOEK | AIR |
| 2 | Oct 2025 | UNDP | DR Congo | Tablet | 648.0K | NOS | $0.099 | $64K | HYDERABAD AIR | KINSHASA | AIR |
| 3 | Oct 2025 | THE MISSION DIRECTOR | Nigeria | Tablet | 2.1M | NOS | $0.100 | $215K | HYDERABAD AIR | ABUJA | AIR |
| 4 | Oct 2025 | THE MISSION DIRECTOR | Nigeria | Tablet | 2.3M | NOS | $0.100 | $231K | HYDERABAD AIR | ABUJA | AIR |
| 5 | Oct 2025 | THE MISSION DIRECTOR | Nigeria | Tablet | 2.2M | NOS | $0.100 | $221K | HYDERABAD AIR | ABUJA | AIR |
| 6 | Oct 2025 | THE MISSION DIRECTOR | Nigeria | Tablet | 2.2M | NOS | $0.100 | $220K | HYDERABAD AIR | ABUJA | AIR |
| 7 | Oct 2025 | THE MISSION DIRECTOR | Nigeria | Tablet | 2.2M | NOS | $0.100 | $216K | HYDERABAD AIR | ABUJA | AIR |
| 8 | Oct 2025 | THE MISSION DIRECTOR | Nigeria | Tablet | 816.5K | NOS | $0.100 | $82K | HYDERABAD AIR | ABUJA | AIR |
| 9 | Oct 2025 | THE MISSION DIRECTOR | Nigeria | Tablet | 2.2M | NOS | $0.100 | $219K | HYDERABAD AIR | ABUJA | AIR |
| 10 | Oct 2025 | THE MISSION DIRECTOR | Nigeria | Tablet | 2.2M | NOS | $0.100 | $218K | HYDERABAD AIR | ABUJA | AIR |
| 11 | Oct 2025 | THE MISSION DIRECTOR | Nigeria | Tablet | 2.2M | NOS | $0.100 | $217K | HYDERABAD AIR | ABUJA | AIR |
| 12 | Oct 2025 | UNLISTED BUYER | Tanzania | Tablet | 11.9M | NOS | $0.099 | $1.18M | NHAVA SHEVA SEA (JNPT) | Dar Es Salaam | SEA |
| 13 | Oct 2025 | UNLISTED BUYER | DR Congo | Tablet | 6.6M | NOS | $0.097 | $638K | NHAVA SHEVA SEA (JNPT) | Kinshasa | SEA |
| 14 | Oct 2025 | UNLISTED BUYER | Tanzania | Tablet | 23.2M | NOS | $0.099 | $2.30M | NHAVA SHEVA SEA (JNPT) | Dar Es Salaam | SEA |
| 15 | Oct 2025 | UNLISTED BUYER | South Africa | Tablet | 8.0M | NOS | $0.099 | $791K | NHAVA SHEVA SEA (JNPT) | Durban | SEA |
| 16 | Oct 2025 | TRIDENT HEALTHCARE LTD | Mauritius | Tablet | 20.2K | NOS | $0.027 | $545.42 | HYDERABAD AIR | MAURITIUS | AIR |
| 17 | Nov 2025 | UNLISTED BUYER | South Africa | 11.9M | NOS | $0.099 | $1.18M | NHAVA SHEVA SEA (JNPT) | Durban | SEA | |
| 18 | Nov 2025 | UNLISTED BUYER | South Africa | 11.9M | NOS | $0.099 | $1.18M | NHAVA SHEVA SEA (JNPT) | Durban | SEA | |
| 19 | Nov 2025 | MINISTRY OF HEALTH OF THE | Tanzania | Tablet | 14.9M | NOS | $0.091 | $1.35M | NHAVA SHEVA SEA (JNPT) | Dar Es Salaam | SEA |
| 20 | Nov 2025 | UNLISTED BUYER | Botswana | 76.6K | SET | $3.87 | $297K | MUMBAI AIR (SAHAR) | GABORONE | AIR | |
| 21 | Nov 2025 | UNKNOWN BUYER | South Africa | 11.9M | NOS | $0.100 | $1.19M | NHAVA SHEVA SEA (JNPT) | Durban | SEA | |
| 22 | Nov 2025 | UNKNOWN BUYER | South Africa | 6.0M | NOS | $0.100 | $595K | NHAVA SHEVA SEA (JNPT) | Durban | SEA | |
| 23 | Nov 2025 | UNLISTED BUYER | Kenya | Tablet | 23.8M | NOS | $0.100 | $2.38M | NHAVA SHEVA SEA (JNPT) | Mombasa | SEA |
| 24 | Nov 2025 | UNLISTED BUYER | South Africa | Tablet | 5.8M | NOS | $0.092 | $537K | NHAVA SHEVA SEA (JNPT) | Durban | SEA |
| 25 | Nov 2025 | SECRETARIAT EXECUTIF NATIONAL DE | Mauritania | disopr | 285.1K | NOS | $0.094 | $27K | NHAVA SHEVA SEA (JNPT) | Nouakchott | SEA |
| 26 | Nov 2025 | SECRETARIAT EXECUTIF NATIONAL DE | Mauritania | disopr | 1.3M | NOS | $0.093 | $122K | NHAVA SHEVA SEA (JNPT) | Nouakchott | SEA |
| 27 | Dec 2025 | UNLISTED BUYER | South Africa | Tablet | 6.0M | NOS | $0.100 | $596K | NHAVA SHEVA SEA (JNPT) | Durban | SEA |
| 28 | Dec 2025 | SECRETARIAT EXECUTIF NATIONAL DE | Mauritania | Tablet | 90.7K | NOS | $0.0011 | $97.13 | MUMBAI AIR (SAHAR) | NOUAKCHOTT | AIR |
| 29 | Dec 2025 | SECRETARIAT EXECUTIF NATIONAL DE | Mauritania | Tablet | 73.4K | NOS | $0.0004 | $26.49 | MUMBAI AIR (SAHAR) | NOUAKCHOTT | AIR |
| 30 | Dec 2025 | SECRETARIAT EXECUTIF NATIONAL DE | Mauritania | Tablet | 90.7K | NOS | $0.0011 | $96.44 | MUMBAI AIR (SAHAR) | NOUAKCHOTT | SEA |
| SUPPLIER #2 — CIPLA LTD · 90 shipments · $7.72M | |||||||||||
| 31 | Oct 2025 | NATIONAL COUNCIL FOR THE STRUGGLEAG | Burkina Faso | Tablet | 1.2M | NOS | $0.090 | $106K | NHAVA SHEVA SEA (JNPT) | Abidjan | SEA |
| 32 | Oct 2025 | NATIONAL COUNCIL FOR THE STRUGGLEAG | Burkina Faso | Tablet | 446.4K | NOS | $0.090 | $40K | NHAVA SHEVA SEA (JNPT) | Abidjan | SEA |
| 33 | Oct 2025 | MEDPRO PHARMACEUTICA PTY LTD | South Africa | Tablet | 155.5K | NOS | $0.173 | $27K | NHAVA SHEVA SEA (JNPT) | Cape Town | SEA |
| 34 | Oct 2025 | MEDPRO PHARMACEUTICA PTY LTD | South Africa | Tablet | 157.5K | NOS | $0.173 | $27K | NHAVA SHEVA SEA (JNPT) | Cape Town | SEA |
| 35 | Oct 2025 | BUREAU DU PNUD UNDP IN CONGOCROISEM | Republic of the Congo | Tablet | 1.2M | NOS | $0.084 | $99K | NHAVA SHEVA SEA (JNPT) | Brazzaville | SEA |
| 36 | Oct 2025 | BUREAU DU PNUD UNDP IN CONGOCROISEM | Republic of the Congo | Tablet | 1.2M | NOS | $0.084 | $98K | NHAVA SHEVA SEA (JNPT) | Brazzaville | SEA |
| 37 | Oct 2025 | BUREAU DU PNUD UNDP IN CONGOCROISEM | Republic of the Congo | Tablet | 837.0K | NOS | $0.084 | $70K | NHAVA SHEVA SEA (JNPT) | Brazzaville | SEA |
| 38 | Oct 2025 | BUREAU DU PNUD UNDP IN CONGOCROISEM | Republic of the Congo | Tablet | 1.2M | NOS | $0.084 | $99K | NHAVA SHEVA SEA (JNPT) | Brazzaville | SEA |
| 39 | Oct 2025 | BUREAU DU PNUD UNDP IN CONGOCROISEM | Republic of the Congo | Tablet | 11.3K | NOS | $0.084 | $955.12 | NHAVA SHEVA SEA (JNPT) | Brazzaville | SEA |
| 40 | Dec 2025 | NATIONAL EMERGENCY RESPONSE COUNCIL | South Africa | Tablet | 1.2M | NOS | $0.085 | $100K | NHAVA SHEVA SEA (JNPT) | Durban | SEA |
| 41 | Dec 2025 | NATIONAL EMERGENCY RESPONSE COUNCIL | South Africa | Tablet | 1.2M | NOS | $0.085 | $100K | NHAVA SHEVA SEA (JNPT) | Durban | SEA |
| 42 | Dec 2025 | NATIONAL EMERGENCY RESPONSE COUNCIL | South Africa | Tablet | 1.2M | NOS | $0.085 | $99K | NHAVA SHEVA SEA (JNPT) | Durban | SEA |
| 43 | Dec 2025 | NATIONAL EMERGENCY RESPONSE COUNCIL | South Africa | Tablet | 1.2M | NOS | $0.085 | $99K | NHAVA SHEVA SEA (JNPT) | Durban | SEA |
| 44 | Dec 2025 | NATIONAL EMERGENCY RESPONSE COUNCIL | South Africa | Tablet | 1.2M | NOS | $0.085 | $99K | NHAVA SHEVA SEA (JNPT) | Durban | SEA |
| 45 | Dec 2025 | NATIONAL EMERGENCY RESPONSE COUNCIL | South Africa | Tablet | 1.2M | NOS | $0.085 | $99K | NHAVA SHEVA SEA (JNPT) | Durban | SEA |
| 46 | Dec 2025 | NATIONAL EMERGENCY RESPONSE COUNCIL | South Africa | Tablet | 1.2M | NOS | $0.085 | $99K | NHAVA SHEVA SEA (JNPT) | Durban | SEA |
| 47 | Dec 2025 | NATIONAL EMERGENCY RESPONSE COUNCIL | South Africa | Tablet | 1.2M | NOS | $0.085 | $99K | NHAVA SHEVA SEA (JNPT) | Durban | SEA |
| 48 | Dec 2025 | NATIONAL EMERGENCY RESPONSE COUNCIL | South Africa | Tablet | 1.2M | NOS | $0.085 | $99K | NHAVA SHEVA SEA (JNPT) | Durban | SEA |
| 49 | Dec 2025 | NATIONAL EMERGENCY RESPONSE COUNCIL | South Africa | Tablet | 1.2M | NOS | $0.085 | $99K | NHAVA SHEVA SEA (JNPT) | Durban | SEA |
| 50 | Dec 2025 | NATIONAL EMERGENCY RESPONSE COUNCIL | South Africa | Tablet | 1.2M | NOS | $0.085 | $99K | NHAVA SHEVA SEA (JNPT) | Durban | SEA |
| 51 | Dec 2025 | NATIONAL EMERGENCY RESPONSE COUNCIL | South Africa | Tablet | 1.2M | NOS | $0.085 | $99K | NHAVA SHEVA SEA (JNPT) | Durban | SEA |
| 52 | Dec 2025 | NATIONAL EMERGENCY RESPONSE COUNCIL | South Africa | Tablet | 1.2M | NOS | $0.085 | $99K | NHAVA SHEVA SEA (JNPT) | Durban | SEA |
| 53 | Dec 2025 | NATIONAL EMERGENCY RESPONSE COUNCIL | South Africa | Tablet | 1.2M | NOS | $0.085 | $99K | NHAVA SHEVA SEA (JNPT) | Durban | SEA |
| 54 | Dec 2025 | NATIONAL EMERGENCY RESPONSE COUNCIL | South Africa | Tablet | 1.2M | NOS | $0.085 | $99K | NHAVA SHEVA SEA (JNPT) | Durban | SEA |
| 55 | Dec 2025 | NATIONAL EMERGENCY RESPONSE COUNCIL | South Africa | Tablet | 1.2M | NOS | $0.085 | $99K | NHAVA SHEVA SEA (JNPT) | Durban | SEA |
| 56 | Dec 2025 | NATIONAL EMERGENCY RESPONSE COUNCIL | South Africa | Tablet | 1.2M | NOS | $0.085 | $99K | NHAVA SHEVA SEA (JNPT) | Durban | SEA |
| 57 | Dec 2025 | NATIONAL EMERGENCY RESPONSE COUNCIL | South Africa | Tablet | 1.2M | NOS | $0.085 | $99K | NHAVA SHEVA SEA (JNPT) | Durban | SEA |
| 58 | Dec 2025 | NATIONAL EMERGENCY RESPONSE COUNCIL | South Africa | Tablet | 1.1M | NOS | $0.085 | $92K | NHAVA SHEVA SEA (JNPT) | Durban | SEA |
| 59 | Dec 2025 | NATIONAL EMERGENCY RESPONSE COUNCIL | South Africa | Tablet | 970.6K | NOS | $0.085 | $83K | NHAVA SHEVA SEA (JNPT) | Durban | SEA |
| 60 | Dec 2025 | NATIONAL EMERGENCY RESPONSE COUNCIL | South Africa | Tablet | 441.0K | NOS | $0.085 | $37K | NHAVA SHEVA SEA (JNPT) | Durban | SEA |
| 61 | Dec 2025 | NATIONAL EMERGENCY RESPONSE COUNCIL | South Africa | Tablet | 378.0K | NOS | $0.085 | $32K | NHAVA SHEVA SEA (JNPT) | Durban | SEA |
| 62 | Dec 2025 | NATIONAL EMERGENCY RESPONSE COUNCIL | South Africa | Tablet | 352.8K | NOS | $0.085 | $30K | NHAVA SHEVA SEA (JNPT) | Durban | SEA |
| 63 | Dec 2025 | PROGRAMME NATIONAL DE LUTTE CONTRE | Cote d'Ivoire | Tablet | 1.2M | NOS | $0.087 | $101K | NHAVA SHEVA SEA (JNPT) | Abidjan | SEA |
| 64 | Dec 2025 | PROGRAMME NATIONAL DE LUTTE CONTRE | Cote d'Ivoire | Tablet | 1.2M | NOS | $0.087 | $101K | NHAVA SHEVA SEA (JNPT) | Abidjan | SEA |
| 65 | Dec 2025 | PROGRAMME NATIONAL DE LUTTE CONTRE | Cote d'Ivoire | Tablet | 743.4K | NOS | $0.087 | $64K | NHAVA SHEVA SEA (JNPT) | Abidjan | SEA |
| 66 | Dec 2025 | PROGRAMME NATIONAL DE LUTTE CONTRE | Cote d'Ivoire | Tablet | 201.6K | NOS | $0.087 | $17K | NHAVA SHEVA SEA (JNPT) | Abidjan | SEA |
| 67 | Dec 2025 | PROGRAMME NATIONAL DE LUTTE CONTRE | Cote d'Ivoire | Tablet | 1.2M | NOS | $0.087 | $101K | NHAVA SHEVA SEA (JNPT) | Abidjan | SEA |
| 68 | Dec 2025 | PROGRAMME NATIONAL DE LUTTE CONTRE | Cote d'Ivoire | Tablet | 1.2M | NOS | $0.087 | $101K | NHAVA SHEVA SEA (JNPT) | Abidjan | SEA |
| 69 | Dec 2025 | PROGRAMME NATIONAL DE LUTTE CONTRE | Cote d'Ivoire | Tablet | 1.2M | NOS | $0.087 | $101K | NHAVA SHEVA SEA (JNPT) | Abidjan | SEA |
| 70 | Dec 2025 | PROGRAMME NATIONAL DE LUTTE CONTRE | Cote d'Ivoire | Tablet | 1.2M | NOS | $0.087 | $101K | NHAVA SHEVA SEA (JNPT) | Abidjan | SEA |
| 71 | Dec 2025 | PROGRAMME NATIONAL DE LUTTE CONTRE | Cote d'Ivoire | Tablet | 1.2M | NOS | $0.087 | $101K | NHAVA SHEVA SEA (JNPT) | Abidjan | SEA |
| 72 | Dec 2025 | PROGRAMME NATIONAL DE LUTTE CONTRE | Cote d'Ivoire | Tablet | 1.2M | NOS | $0.087 | $101K | NHAVA SHEVA SEA (JNPT) | Abidjan | SEA |
| 73 | Dec 2025 | PROGRAMME NATIONAL DE LUTTE CONTRE | Cote d'Ivoire | Tablet | 1.2M | NOS | $0.087 | $101K | NHAVA SHEVA SEA (JNPT) | Abidjan | SEA |
| 74 | Dec 2025 | PROGRAMME NATIONAL DE LUTTE CONTRE | Cote d'Ivoire | Tablet | 1.2M | NOS | $0.087 | $101K | NHAVA SHEVA SEA (JNPT) | Abidjan | SEA |
| 75 | Dec 2025 | PROGRAMME NATIONAL DE LUTTE CONTRE | Cote d'Ivoire | Tablet | 1.2M | NOS | $0.087 | $101K | NHAVA SHEVA SEA (JNPT) | Abidjan | SEA |
| 76 | Dec 2025 | PROGRAMME NATIONAL DE LUTTE CONTRE | Cote d'Ivoire | Tablet | 1.2M | NOS | $0.087 | $101K | NHAVA SHEVA SEA (JNPT) | Abidjan | SEA |
| 77 | Dec 2025 | PROGRAMME NATIONAL DE LUTTE CONTRE | Cote d'Ivoire | Tablet | 1.2M | NOS | $0.087 | $101K | NHAVA SHEVA SEA (JNPT) | Abidjan | SEA |
| 78 | Dec 2025 | PROGRAMME NATIONAL DE LUTTE CONTRE | Cote d'Ivoire | Tablet | 1.2M | NOS | $0.087 | $101K | NHAVA SHEVA SEA (JNPT) | Abidjan | SEA |
| 79 | Dec 2025 | PROGRAMME NATIONAL DE LUTTE CONTRE | Cote d'Ivoire | Tablet | 1.2M | NOS | $0.087 | $101K | NHAVA SHEVA SEA (JNPT) | Abidjan | SEA |
| 80 | Dec 2025 | PROGRAMME NATIONAL DE LUTTE CONTRE | Cote d'Ivoire | Tablet | 1.2M | NOS | $0.087 | $101K | NHAVA SHEVA SEA (JNPT) | Abidjan | SEA |
| 81 | Dec 2025 | PROGRAMME NATIONAL DE LUTTE CONTRE | Cote d'Ivoire | Tablet | 1.2M | NOS | $0.087 | $101K | NHAVA SHEVA SEA (JNPT) | Abidjan | SEA |
| 82 | Dec 2025 | PROGRAMME NATIONAL DE LUTTE CONTRE | Cote d'Ivoire | Tablet | 1.2M | NOS | $0.087 | $101K | NHAVA SHEVA SEA (JNPT) | Abidjan | SEA |
| 83 | Dec 2025 | PROGRAMME NATIONAL DE LUTTE CONTRE | Cote d'Ivoire | Tablet | 1.2M | NOS | $0.087 | $101K | NHAVA SHEVA SEA (JNPT) | Abidjan | SEA |
| 84 | Dec 2025 | PROGRAMME NATIONAL DE LUTTE CONTRE | Cote d'Ivoire | Tablet | 1.2M | NOS | $0.087 | $101K | NHAVA SHEVA SEA (JNPT) | Abidjan | SEA |
| 85 | Dec 2025 | PROGRAMME NATIONAL DE LUTTE CONTRE | Cote d'Ivoire | Tablet | 1.2M | NOS | $0.087 | $101K | NHAVA SHEVA SEA (JNPT) | Abidjan | SEA |
| 86 | Dec 2025 | PROGRAMME NATIONAL DE LUTTE CONTRE | Cote d'Ivoire | Tablet | 1.2M | NOS | $0.087 | $100K | NHAVA SHEVA SEA (JNPT) | Abidjan | SEA |
| 87 | Dec 2025 | PROGRAMME NATIONAL DE LUTTE CONTRE | Cote d'Ivoire | Tablet | 225.0K | NOS | $0.087 | $20K | NHAVA SHEVA SEA (JNPT) | Abidjan | SEA |
| 88 | Dec 2025 | PROGRAMME NATIONAL DE LUTTE CONTRE | Cote d'Ivoire | Tablet | 182.7K | NOS | $0.087 | $16K | NHAVA SHEVA SEA (JNPT) | Abidjan | SEA |
| 89 | Dec 2025 | PROGRAMME NATIONAL DE LUTTE CONTRE | Cote d'Ivoire | Tablet | 100.8K | NOS | $0.087 | $9K | NHAVA SHEVA SEA (JNPT) | Abidjan | SEA |
| 90 | Dec 2025 | MINISTRY OF HEALTH AND CHILD CARE | Zimbabwe | Tablet | 1.2M | NOS | $0.083 | $96K | NHAVA SHEVA SEA (JNPT) | Harare | SEA |
| 91 | Dec 2025 | MINISTRY OF HEALTH AND CHILD CARE | Zimbabwe | Tablet | 1.2M | NOS | $0.083 | $96K | NHAVA SHEVA SEA (JNPT) | Harare | SEA |
| 92 | Dec 2025 | MINISTRY OF HEALTH AND CHILD CARE | Zimbabwe | Tablet | 1.2M | NOS | $0.083 | $96K | NHAVA SHEVA SEA (JNPT) | Harare | SEA |
| 93 | Dec 2025 | MINISTRY OF HEALTH AND CHILD CARE | Zimbabwe | Tablet | 1.2M | NOS | $0.083 | $96K | NHAVA SHEVA SEA (JNPT) | Harare | SEA |
| 94 | Dec 2025 | MINISTRY OF HEALTH AND CHILD CARE | Zimbabwe | Tablet | 1.2M | NOS | $0.083 | $97K | NHAVA SHEVA SEA (JNPT) | Harare | SEA |
| 95 | Dec 2025 | MINISTRY OF HEALTH AND CHILD CARE | Zimbabwe | Tablet | 1.2M | NOS | $0.083 | $96K | NHAVA SHEVA SEA (JNPT) | Harare | SEA |
| 96 | Dec 2025 | MINISTRY OF HEALTH AND CHILD CARE | Zimbabwe | Tablet | 1.2M | NOS | $0.083 | $96K | NHAVA SHEVA SEA (JNPT) | Harare | SEA |
| 97 | Dec 2025 | MINISTRY OF HEALTH AND CHILD CARE | Zimbabwe | Tablet | 1.2M | NOS | $0.083 | $96K | NHAVA SHEVA SEA (JNPT) | Harare | SEA |
| 98 | Dec 2025 | MINISTRY OF HEALTH AND CHILD CARE | Zimbabwe | Tablet | 1.2M | NOS | $0.083 | $96K | NHAVA SHEVA SEA (JNPT) | Harare | SEA |
| 99 | Dec 2025 | MINISTRY OF HEALTH AND CHILD CARE | Zimbabwe | Tablet | 1.2M | NOS | $0.083 | $96K | NHAVA SHEVA SEA (JNPT) | Harare | SEA |
| 100 | Dec 2025 | MINISTRY OF HEALTH AND CHILD CARE | Zimbabwe | Tablet | 415.8K | NOS | $0.083 | $34K | NHAVA SHEVA SEA (JNPT) | Harare | SEA |
| 101 | Dec 2025 | MINISTRY OF HEALTH AND CHILD CARE | Zimbabwe | Tablet | 1.2M | NOS | $0.083 | $96K | NHAVA SHEVA SEA (JNPT) | Harare | SEA |
| 102 | Dec 2025 | MINISTRY OF HEALTH AND CHILD CARE | Zimbabwe | Tablet | 1.2M | NOS | $0.083 | $96K | NHAVA SHEVA SEA (JNPT) | Harare | SEA |
| 103 | Dec 2025 | MINISTRY OF HEALTH AND CHILD CARE | Zimbabwe | Tablet | 1.2M | NOS | $0.083 | $96K | NHAVA SHEVA SEA (JNPT) | Harare | SEA |
| 104 | Dec 2025 | MINISTRY OF HEALTH AND CHILD CARE | Zimbabwe | Tablet | 1.2M | NOS | $0.083 | $96K | NHAVA SHEVA SEA (JNPT) | Harare | SEA |
| 105 | Dec 2025 | MINISTRY OF HEALTH AND CHILD CARE | Zimbabwe | Tablet | 1.2M | NOS | $0.083 | $97K | NHAVA SHEVA SEA (JNPT) | Harare | SEA |
| 106 | Dec 2025 | MINISTRY OF HEALTH AND CHILD CARE | Zimbabwe | Tablet | 1.2M | NOS | $0.083 | $96K | NHAVA SHEVA SEA (JNPT) | Harare | SEA |
| 107 | Dec 2025 | MINISTRY OF HEALTH AND CHILD CARE | Zimbabwe | Tablet | 1.2M | NOS | $0.083 | $96K | NHAVA SHEVA SEA (JNPT) | Harare | SEA |
| 108 | Dec 2025 | MINISTRY OF HEALTH AND CHILD CARE | Zimbabwe | Tablet | 1.2M | NOS | $0.083 | $96K | NHAVA SHEVA SEA (JNPT) | Harare | SEA |
| 109 | Dec 2025 | MINISTRY OF HEALTH AND CHILD CARE | Zimbabwe | Tablet | 1.2M | NOS | $0.083 | $96K | NHAVA SHEVA SEA (JNPT) | Harare | SEA |
| 110 | Dec 2025 | MINISTRY OF HEALTH AND CHILD CARE | Zimbabwe | Tablet | 938.7K | NOS | $0.083 | $78K | NHAVA SHEVA SEA (JNPT) | Harare | SEA |
| 111 | Dec 2025 | MINISTRY OF HEALTH AND CHILD CARE | Zimbabwe | Tablet | 1.2M | NOS | $0.083 | $96K | NHAVA SHEVA SEA (JNPT) | Harare | SEA |
| 112 | Dec 2025 | MINISTRY OF HEALTH AND CHILD CARE | Zimbabwe | Tablet | 1.2M | NOS | $0.083 | $96K | NHAVA SHEVA SEA (JNPT) | Harare | SEA |
| 113 | Dec 2025 | MINISTRY OF HEALTH AND CHILD CARE | Zimbabwe | Tablet | 144.9K | NOS | $0.083 | $12K | NHAVA SHEVA SEA (JNPT) | Harare | SEA |
| 114 | Dec 2025 | MINISTRY OF HEALTH AND CHILD CARE | Zimbabwe | Tablet | 1.2M | NOS | $0.083 | $96K | NHAVA SHEVA SEA (JNPT) | Harare | SEA |
| 115 | Dec 2025 | MINISTRY OF HEALTH AND CHILD CARE | Zimbabwe | Tablet | 1.2M | NOS | $0.083 | $96K | NHAVA SHEVA SEA (JNPT) | Harare | SEA |
| 116 | Dec 2025 | MINISTRY OF HEALTH AND CHILD CARE | Zimbabwe | Tablet | 1.2M | NOS | $0.083 | $96K | NHAVA SHEVA SEA (JNPT) | Harare | SEA |
| 117 | Dec 2025 | MINISTRY OF HEALTH AND CHILD CARE | Zimbabwe | Tablet | 1.1M | NOS | $0.083 | $92K | NHAVA SHEVA SEA (JNPT) | Harare | SEA |
| 118 | Dec 2025 | MINISTRY OF HEALTH AND CHILD CARE | Zimbabwe | Tablet | 1.2M | NOS | $0.083 | $96K | NHAVA SHEVA SEA (JNPT) | Harare | SEA |
| 119 | Dec 2025 | MINISTRY OF HEALTH AND CHILD CARE | Zimbabwe | Tablet | 1.2M | NOS | $0.083 | $96K | NHAVA SHEVA SEA (JNPT) | Harare | SEA |
| 120 | Dec 2025 | MINISTRY OF HEALTH AND CHILD CARE | Zimbabwe | Tablet | 415.8K | NOS | $0.083 | $34K | NHAVA SHEVA SEA (JNPT) | Harare | SEA |
| SUPPLIER #3 — EMCURE PHARMACEUTICALS LTD · 16 shipments · $5.57M | |||||||||||
| 121 | Oct 2025 | NATIONAL DRUGS SERVICE ORGANIZATION | Lesotho | Tablet | 80.9K | NOS | $6.98 | $564K | NHAVA SHEVA SEA (JNPT) | Mafeteng | SEA |
| 122 | Oct 2025 | NATIONAL DRUGS SERVICE ORGANIZATION | Lesotho | Tablet | 80.8K | NOS | $6.98 | $564K | NHAVA SHEVA SEA (JNPT) | Mafeteng | SEA |
| 123 | Oct 2025 | NATIONAL DRUGS SERVICE ORGANIZATION | Lesotho | Tablet | 74.7K | NOS | $6.98 | $521K | NHAVA SHEVA SEA (JNPT) | Mafeteng | SEA |
| 124 | Oct 2025 | MINISTRY OF HEALTH AND CHILD CAREC/ | Zimbabwe | Tablet | 136.2K | NOS | $0.893 | $122K | NHAVA SHEVA SEA (JNPT) | Beira | SEA |
| 125 | Dec 2025 | EMCURE PHARMACEUTICALS SA (PTY) LTD | South Africa | Tablet | 37.5K | NOS | $7.14 | $268K | AHMEDABAD AIR | JOHANNESBURG - JOHAN | AIR |
| 126 | Dec 2025 | EMCURE PHARMACEUTICALS SA (PTY) LTD | South Africa | Tablet | 37.9K | NOS | $7.36 | $279K | AHMEDABAD AIR | JOHANNESBURG - JOHAN | AIR |
| 127 | Dec 2025 | EMCURE PHARMACEUTICALS SA (PTY) LTD | South Africa | Tablet | 49.9K | NOS | $7.52 | $375K | AHMEDABAD AIR | JOHANNESBURG - JOHAN | AIR |
| 128 | Dec 2025 | THE MAURITIUS PHARMACY (SEEGOBIN) L | Mauritius | Tablet | 3.7K | NOS | $0.036 | $132.74 | MUMBAI AIR (SAHAR) | MAURITIUS | AIR |
| 129 | Dec 2025 | EMCURE PHARMACEUTICALS SA (PTY) LTD | South Africa | Tablet | 38.2K | NOS | $7.82 | $299K | AHMEDABAD AIR | JOHANNESBURG - JOHAN | AIR |
| 130 | Dec 2025 | THE MINISTRY OF HEALTH AND SOCIAL S | Namibia | Tablet | 68.3K | NOS | $0.083 | $6K | NHAVA SHEVA SEA (JNPT) | Windhoek | SEA |
| 131 | Dec 2025 | EMCURE PHARMACEUTICALS SA (PTY) LTD | South Africa | Tablet | 50.8K | NOS | $8.11 | $412K | AHMEDABAD AIR | JOHANNESBURG - JOHAN | AIR |
| 132 | Dec 2025 | NATIONAL EMERGENCY RESPONSE COUNCIL | South Africa | Tablet | 73.6K | NOS | $1.02 | $75K | NHAVA SHEVA SEA (JNPT) | Durban | SEA |
| 133 | Dec 2025 | NATIONAL EMERGENCY RESPONSE COUNCIL | South Africa | Tablet | 194.6K | NOS | $7.85 | $1.53M | NHAVA SHEVA SEA (JNPT) | Durban | SEA |
| 134 | Dec 2025 | UNDP/GLOBAL FUND PROJECT | Angola | Tablet | 13.9K | NOS | $0.921 | $13K | MUMBAI AIR (SAHAR) | LUANDA - | AIR |
| 135 | Dec 2025 | THE MINISTRY OF HEALTH AND SOCIAL S | Namibia | Tablet | 50.0K | NOS | $0.947 | $47K | NHAVA SHEVA SEA (JNPT) | Walvis Bay | SEA |
| 136 | Dec 2025 | THE MINISTRY OF HEALTH AND SOCIAL S | Namibia | Tablet | 66.8K | NOS | $7.45 | $497K | NHAVA SHEVA SEA (JNPT) | Walvis Bay | SEA |
| SUPPLIER #4 — SUN PHARMACEUTICAL INDUSTRIES LTD · 1 shipments · $2.20M | |||||||||||
| 137 | Oct 2025 | MINISTERIO DA SA | Mozambique | Tablet | 23.4M | NOS | $0.094 | $2.20M | DADRI ICD | NACALA | ICD |
| SUPPLIER #5 — M D PHARMACY · 6 shipments · $2.18M | |||||||||||
| 138 | Oct 2025 | OFFICE PHARMACEUTIQUE NATIONAL (OPN | Gabon | Tablet | 24.5K | NOS | $18.24 | $447K | MUNDRA SEA | Libreville | SEA |
| 139 | Oct 2025 | OFFICE PHARMACEUTIQUE NATIONAL (OPN | Gabon | Tablet | 13.6K | NOS | $17.76 | $242K | AHMEDABAD AIR | LIBREVILLE | AIR |
| 140 | Nov 2025 | OFFICE PHARMACEUTIQUE NATIONAL (OPN | Gabon | 27.2K | NOS | $17.69 | $482K | AHMEDABAD AIR | LIBREVILLE | AIR | |
| 141 | Nov 2025 | UNKNOWN BUYER | Gabon | 27.2K | NOS | $17.69 | $482K | AHMEDABAD AIR | LIBREVILLE | AIR | |
| 142 | Nov 2025 | OFFICE PHARMACEUTIQUE NATIONAL (OPN | Gabon | 27.2K | NOS | $17.69 | $482K | MUMBAI AIR (SAHAR) | LIBREVILLE | AIR | |
| 143 | Nov 2025 | OFFICE PHARMACEUTIQUE NATIONAL (OPN | Gabon | Tablet | 2.6K | NOS | $18.72 | $49K | AHMEDABAD AIR | LIBREVILLE | AIR |
| SUPPLIER #6 — MACLEODS PHARMACEUTICALS LTD · 8 shipments · $54K | |||||||||||
| 144 | Nov 2025 | US EMBASSY (C) | Tanzania | Dispersible Tablet | 67.0K | NOS | $0.043 | $3K | MUMBAI AIR (SAHAR) | ZANZIBAR | AIR |
| 145 | Dec 2025 | PROGRAMME DES NATIONS UNIES POUR LE | Republic of the Congo | Tablet | 801.9K | NOS | $0.0005 | $431.29 | MUMBAI AIR (SAHAR) | BRAZZAVILLE | AIR |
| 146 | Dec 2025 | US EMBASSY MBABANE | South Africa | Tablet | 42.8K | NOS | $0.0000 | $0.0000 | MUMBAI AIR (SAHAR) | JOHANNESBURG - JOHAN | AIR |
| 147 | Dec 2025 | INTERMED ANGOLA, LDA | Angola | Tablet | 1.2K | NOS | $0.048 | $57.19 | MUMBAI AIR (SAHAR) | LUANDA - | AIR |
| 148 | Dec 2025 | INTERMED ANGOLA, LDA | Angola | Tablet | 98.8K | NOS | $0.048 | $5K | MUMBAI AIR (SAHAR) | LUANDA - | AIR |
| 149 | Dec 2025 | INTERMED ANGOLA, LDA | Angola | Tablet | 1.2K | NOS | $0.051 | $60.96 | MUMBAI AIR (SAHAR) | LUANDA - | AIR |
| 150 | Dec 2025 | INTERMED ANGOLA, LDA | Angola | Tablet | 98.8K | NOS | $0.051 | $5K | MUMBAI AIR (SAHAR) | LUANDA - | AIR |
| 151 | Dec 2025 | UNDP SOUTH SUDAN | South Sudan | Dispersible Tablet | 855.0K | NOS | $0.048 | $41K | DELHI AIR | JUBA | AIR |
| SUPPLIER #7 — MICRO LABS LTD · 3 shipments · $44K | |||||||||||
| 152 | Nov 2025 | MINISTRY OF HEALTH & CHILD CARE | Zimbabwe | Tablet | 348 | KGS | $119.90 | $42K | MUMBAI AIR (SAHAR) | HARARE | AIR |
| 153 | Dec 2025 | MINISTRY OF HEALTH AND CHILD CARE | Zimbabwe | Tablet | 1.2K | KGS | $1.38 | $2K | NHAVA SHEVA SEA (JNPT) | Harare | SEA |
| 154 | Dec 2025 | MINISTRY OF HEALTH AND CHILD CARE | Zimbabwe | Tablet | 10.3K | PCS | $0.081 | $829.88 | NHAVA SHEVA SEA (JNPT) | Harare | SEA |
| SUPPLIER #8 — SHARVIK IMPEX (INDIA) PVT LTD · 1 shipments · $14.61 | |||||||||||
| 155 | Dec 2025 | P.F.ASSELBERGS | Madagascar | Tablet | 1 | NOS | $14.61 | $14.61 | MUMBAI AIR (SAHAR) | ANTANANARIVO | AIR |
10
PART VI — DRILL-DOWN · ASIA
Region: Asia
12 countries · 40 shipments · $1.39M · 12 Indian suppliers · 17 buyers
SHIPMENTS
40
USD
$1.39M
COUNTRIES
12
SUPPLIERS
12
BUYERS
17
HHI
3,044
concentrated
Top 12 destination countries in Asia
1
Vietnam (43.7%)
$606K
2
Malaysia (27.7%)
$383K
3
Sri Lanka (10.0%)
$139K
4
Laos (7.1%)
$98K
5
Philippines (6.8%)
$95K
6
Singapore (2.3%)
$32K
7
Tajikistan (1.0%)
$13K
8
United Arab Emirates (0.5%)
$7K
9
Cambodia (0.4%)
$6K
10
Thailand (0.3%)
$4K
11
Uzbekistan (0.2%)
$2K
12
Azerbaijan (0.0%)
$607.93
Top 12 Indian suppliers into Asia
1
HETERO LABS LTD
$606K
2
SUN PHARMACEUTICAL INDUSTRIES LTD
$381K
3
CIPLA LTD
$252K
4
MICRO LABS LTD
$87K
5
HEET HEALTHCARE PVT LTD
$31K
6
APPLE PHARMACEUTICALS
$8K
7
HOPEWELL SOLUTIONS
$6K
8
EMCURE PHARMACEUTICALS LTD
$6K
9
MACLEODS PHARMACEUTICALS LTD
$5K
10
PINKLINE EXPORTS
$3K
11
LEOWIN HEALTHCARE LLP
$682.52
12
PLEASANT EXPORTS
$455.59
Top 15 Asia importers
1
HOANG DUC PHARMACEUTICAL & · Vietnam
$606K
2
RANBAXY (MALAYSIA) SDN BHD · Malaysia
$190K
3
MEDICAL SUPPLIES DIVISION MOH OF · Sri Lanka
$139K
4
MINISTRY OF HEALTH (CHAS) · Laos
$98K
5
BROWN & BURK PHILIPPINES INC · Philippines
$87K
6
UNITED NATIONS DEVELOPMENTPROGRAMME · Tajikistan
$13K
7
EGCSS INTERNATIONAL CO.FZ · United Arab Emirates
$6K
8
NATIONAL CENTER FOR HIV/AIDS MINIST · Cambodia
$6K
9
SHIP CLINIC INC · Philippines
$4K
10
NSK FORWARDING & TRANSPORTATION · Malaysia
$3K
11
UNITED NATIONS DEVELOPMENT · Uzbekistan
$2K
12
M.S. TERMINAL CO LTD · Thailand
$2K
13
MINISTRY OF HEALTH OF THE · Azerbaijan
$607.93
14
THE ESSES PHARMACY (PVT) LTD · Sri Lanka
$455.59
15
IDA TRADING MEA · United Arab Emirates
$47.84
Top 3 dosage forms
1
Tablet
$1.24M
2
Unknown
$145K
3
Dispersible Tablet
$4K
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 6 | $606K | $101K |
| Nov | 18 | $615K | $34K |
| Dec | 16 | $164K | $10K |
Shipment register · 40 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — HETERO LABS LTD · 5 shipments · $606K | |||||||||||
| 1 | Oct 2025 | HOANG DUC PHARMACEUTICAL & | Vietnam | Tablet | 1.5M | NOS | $0.093 | $140K | HYDERABAD ICD | cat Lai | ICD |
| 2 | Oct 2025 | HOANG DUC PHARMACEUTICAL & | Vietnam | Tablet | 1.5M | NOS | $0.093 | $140K | HYDERABAD ICD | cat Lai | ICD |
| 3 | Oct 2025 | HOANG DUC PHARMACEUTICAL & | Vietnam | Tablet | 526.5K | NOS | $0.093 | $49K | HYDERABAD ICD | cat Lai | ICD |
| 4 | Oct 2025 | HOANG DUC PHARMACEUTICAL & | Vietnam | Tablet | 1.5M | NOS | $0.093 | $139K | HYDERABAD ICD | cat Lai | ICD |
| 5 | Oct 2025 | HOANG DUC PHARMACEUTICAL & | Vietnam | Tablet | 1.5M | NOS | $0.093 | $138K | HYDERABAD ICD | cat Lai | ICD |
| SUPPLIER #2 — SUN PHARMACEUTICAL INDUSTRIES LTD · 3 shipments · $381K | |||||||||||
| 6 | Nov 2025 | RANBAXY (MALAYSIA) SDN BHD | Malaysia | Tablet | 150.7K | NOS | $1.26 | $190K | DELHI AIR | PENANG | AIR |
| 7 | Nov 2025 | UNKNOWN BUYER | Malaysia | Tablet | 150.7K | NOS | $1.26 | $190K | DELHI AIR | PENANG | AIR |
| 8 | Dec 2025 | MINISTRY OF HEALTH OF THE | Azerbaijan | Tablet | 100.7K | NOS | $0.0060 | $607.93 | MUMBAI AIR (SAHAR) | BAKU | AIR |
| SUPPLIER #3 — CIPLA LTD · 8 shipments · $252K | |||||||||||
| 9 | Nov 2025 | MINISTRY OF HEALTH (CHAS) | Laos | 1.1M | NOS | $0.089 | $98K | NHAVA SHEVA SEA (JNPT) | Vientiane | SEA | |
| 10 | Nov 2025 | UNITED NATIONS DEVELOPMENTPROGRAMME | Tajikistan | 96.6K | NOS | $0.087 | $8K | MUMBAI AIR (SAHAR) | DUSHANBE | AIR | |
| 11 | Nov 2025 | UNITED NATIONS DEVELOPMENTPROGRAMME | Tajikistan | 54.6K | NOS | $0.087 | $5K | MUMBAI AIR (SAHAR) | DUSHANBE | AIR | |
| 12 | Dec 2025 | UNITED NATIONS DEVELOPMENT | Uzbekistan | Tablet | 1.2M | NOS | $0.0010 | $1K | NHAVA SHEVA SEA (JNPT) | Tashkent | SEA |
| 13 | Dec 2025 | UNITED NATIONS DEVELOPMENT | Uzbekistan | Tablet | 980.7K | NOS | $0.0010 | $1K | NHAVA SHEVA SEA (JNPT) | Tashkent | SEA |
| 14 | Dec 2025 | UNITED NATIONS DEVELOPMENT | Uzbekistan | Tablet | 176.4K | NOS | $0.0010 | $181.49 | NHAVA SHEVA SEA (JNPT) | Tashkent | SEA |
| 15 | Dec 2025 | MEDICAL SUPPLIES DIVISION MOH OF | Sri Lanka | Tablet | 1.2M | NOS | $0.090 | $105K | NHAVA SHEVA SEA (JNPT) | Colombo | SEA |
| 16 | Dec 2025 | MEDICAL SUPPLIES DIVISION MOH OF | Sri Lanka | Tablet | 371.7K | NOS | $0.090 | $33K | NHAVA SHEVA SEA (JNPT) | Colombo | SEA |
| SUPPLIER #4 — MICRO LABS LTD · 1 shipments · $87K | |||||||||||
| 17 | Nov 2025 | BROWN & BURK PHILIPPINES INC | Philippines | Tablet | 52.8K | PCS | $1.64 | $87K | BANGALORE AIR | MANILA | AIR |
| SUPPLIER #5 — HEET HEALTHCARE PVT LTD · 10 shipments · $31K | |||||||||||
| 18 | Nov 2025 | UNLISTED BUYER | Singapore | 60 | NOS | $69.88 | $4K | AHMEDABAD AIR | SINGAPORE | AIR | |
| 19 | Nov 2025 | UNLISTED BUYER | Singapore | 6 | NOS | $69.88 | $419.28 | AHMEDABAD AIR | SINGAPORE | AIR | |
| 20 | Nov 2025 | UNLISTED BUYER | Singapore | 42 | NOS | $69.88 | $3K | AHMEDABAD AIR | SINGAPORE | AIR | |
| 21 | Nov 2025 | UNKNOWN BUYER | Singapore | 60 | NOS | $69.88 | $4K | AHMEDABAD AIR | SINGAPORE | AIR | |
| 22 | Nov 2025 | UNKNOWN BUYER | Singapore | 6 | NOS | $69.88 | $419.28 | AHMEDABAD AIR | SINGAPORE | AIR | |
| 23 | Nov 2025 | UNKNOWN BUYER | Singapore | 42 | NOS | $69.88 | $3K | AHMEDABAD AIR | SINGAPORE | AIR | |
| 24 | Dec 2025 | UNLISTED BUYER | Singapore | 149 | NOS | $25.51 | $4K | AHMEDABAD AIR | SINGAPORE | AIR | |
| 25 | Dec 2025 | UNLISTED BUYER | Singapore | 113 | NOS | $25.51 | $3K | AHMEDABAD AIR | SINGAPORE | AIR | |
| 26 | Dec 2025 | UNLISTED BUYER | Singapore | 60 | NOS | $25.51 | $2K | AHMEDABAD AIR | SINGAPORE | AIR | |
| 27 | Dec 2025 | UNLISTED BUYER | Singapore | 1.1K | NOS | $7.14 | $8K | AHMEDABAD AIR | SINGAPORE | AIR | |
| SUPPLIER #6 — APPLE PHARMACEUTICALS · 2 shipments · $8K | |||||||||||
| 28 | Nov 2025 | SHIP CLINIC INC | Philippines | Tablet | 200 | NOS | $19.97 | $4K | MUMBAI AIR (SAHAR) | MANILA | AIR |
| 29 | Nov 2025 | UNKNOWN BUYER | Philippines | Tablet | 200 | NOS | $19.97 | $4K | MUMBAI AIR (SAHAR) | MANILA | AIR |
| SUPPLIER #7 — HOPEWELL SOLUTIONS · 1 shipments · $6K | |||||||||||
| 30 | Nov 2025 | EGCSS INTERNATIONAL CO.FZ | United Arab Emirates | Tablet | 200 | NOS | $32.35 | $6K | MUMBAI AIR (SAHAR) | DUBAI | AIR |
| SUPPLIER #8 — EMCURE PHARMACEUTICALS LTD · 2 shipments · $6K | |||||||||||
| 31 | Dec 2025 | NATIONAL CENTER FOR HIV/AIDS MINIST | Cambodia | Tablet | 30.7K | NOS | $0.085 | $3K | MUMBAI AIR (SAHAR) | TECHO INTERNATIONAL | AIR |
| 32 | Dec 2025 | NATIONAL CENTER FOR HIV/AIDS MINIST | Cambodia | Tablet | 39.1K | NOS | $0.085 | $3K | MUMBAI AIR (SAHAR) | TECHO INTERNATIONAL | AIR |
| SUPPLIER #9 — MACLEODS PHARMACEUTICALS LTD · 3 shipments · $5K | |||||||||||
| 33 | Nov 2025 | M.S. TERMINAL CO LTD | Thailand | Dispersible Tablet | 51.4K | NOS | $0.043 | $2K | DELHI AIR | BANGKOK | AIR |
| 34 | Nov 2025 | UNKNOWN BUYER | Thailand | Dispersible Tablet | 51.4K | NOS | $0.043 | $2K | DELHI AIR | BANGKOK | AIR |
| 35 | Dec 2025 | IDA TRADING MEA | United Arab Emirates | Tablet | 120.0K | NOS | $0.0004 | $47.84 | NHAVA SHEVA SEA (JNPT) | Jebel Ali | SEA |
| SUPPLIER #10 — PINKLINE EXPORTS · 1 shipments · $3K | |||||||||||
| 36 | Nov 2025 | NSK FORWARDING & TRANSPORTATION | Malaysia | 357 | NOS | $7.79 | $3K | MUMBAI AIR (SAHAR) | KUALA LUMPUR - INT'L | AIR | |
| SUPPLIER #11 — LEOWIN HEALTHCARE LLP · 3 shipments · $682.52 | |||||||||||
| 37 | Oct 2025 | UNLISTED BUYER | Singapore | Tablet | 500 | NOS | $1.25 | $626.42 | AHMEDABAD AIR | SINGAPORE | AIR |
| 38 | Dec 2025 | UNLISTED BUYER | Singapore | Tablet | 5 | NOS | $1.02 | $5.10 | AHMEDABAD AIR | SINGAPORE | AIR |
| 39 | Dec 2025 | UNLISTED BUYER | Laos | Tablet | 50 | NOS | $1.02 | $51.00 | AHMEDABAD AIR | VIENTIANE | AIR |
| SUPPLIER #12 — PLEASANT EXPORTS · 1 shipments · $455.59 | |||||||||||
| 40 | Dec 2025 | THE ESSES PHARMACY (PVT) LTD | Sri Lanka | Tablet | 20 | NOS | $22.78 | $455.59 | CHENNAI AIR | COLOMBO | AIR |
10
PART VI — DRILL-DOWN · EUROPE
Region: Europe
4 countries · 8 shipments · $265K · 4 Indian suppliers · 4 buyers
SHIPMENTS
8
USD
$265K
COUNTRIES
4
SUPPLIERS
4
BUYERS
4
HHI
9,505
concentrated
Top 4 destination countries in Europe
1
Russia (97.5%)
$258K
2
United Kingdom (1.3%)
$3K
3
Slovenia (1.2%)
$3K
4
Poland (0.1%)
$199.66
Top 4 Indian suppliers into Europe
1
SUN PHARMACEUTICAL INDUSTRIES LTD
$258K
2
NIVIRA EXPORTS
$3K
3
SANDOZ PVT LTD
$3K
4
HEET HEALTHCARE PVT LTD
$199.66
Top 3 Europe importers
1
AO RANBAXY · Russia
$258K
2
TO THE PURCHASE DEPT · United Kingdom
$3K
3
LEK PHARMACEUTICALS D.D · Slovenia
$3K
Top 2 dosage forms
1
Tablet
$265K
2
Unknown
$199.66
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 0 | $0.0000 | — |
| Nov | 6 | $252K | $42K |
| Dec | 2 | $13K | $7K |
Shipment register · 8 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — SUN PHARMACEUTICAL INDUSTRIES LTD · 2 shipments · $258K | |||||||||||
| 1 | Nov 2025 | AO RANBAXY | Russia | Tablet | 16.6K | NOS | $15.03 | $249K | DELHI AIR | SHEREMETYEVO | AIR |
| 2 | Dec 2025 | AO RANBAXY | Russia | Tablet | 18.7K | NOS | $0.512 | $10K | DELHI AIR | SHEREMETYEVO | AIR |
| SUPPLIER #2 — NIVIRA EXPORTS · 1 shipments · $3K | |||||||||||
| 3 | Dec 2025 | TO THE PURCHASE DEPT | United Kingdom | Tablet | 360 | NOS | $9.54 | $3K | MUMBAI AIR (SAHAR) | LONDON - HEATHROW | AIR |
| SUPPLIER #3 — SANDOZ PVT LTD · 3 shipments · $3K | |||||||||||
| 4 | Nov 2025 | LEK PHARMACEUTICALS D.D | Slovenia | Tablet | 40 | NOS | $17.96 | $718.57 | MUMBAI AIR (SAHAR) | LJUBLJANA - BRNIK | AIR |
| 5 | Nov 2025 | LEK PHARMACEUTICALS D.D | Slovenia | Tablet | 4.8K | NOS | $0.110 | $524.65 | MUMBAI AIR (SAHAR) | LJUBLJANA - BRNIK | AIR |
| 6 | Nov 2025 | LEK PHARMACEUTICALS D.D | Slovenia | Tablet | 16.5K | NOS | $0.110 | $2K | MUMBAI AIR (SAHAR) | LJUBLJANA - BRNIK | AIR |
| SUPPLIER #4 — HEET HEALTHCARE PVT LTD · 2 shipments · $199.66 | |||||||||||
| 7 | Nov 2025 | UNLISTED BUYER | Poland | 5 | NOS | $19.97 | $99.83 | AHMEDABAD AIR | WARSAW | AIR | |
| 8 | Nov 2025 | UNLISTED BUYER | Poland | 5 | NOS | $19.97 | $99.83 | AHMEDABAD AIR | WARSAW | AIR | |
10
PART VI — DRILL-DOWN · AMERICAS
Region: Americas
11 countries · 37 shipments · $1.87M · 5 Indian suppliers · 12 buyers
SHIPMENTS
37
USD
$1.87M
COUNTRIES
11
SUPPLIERS
5
BUYERS
12
HHI
4,392
concentrated
Top 11 destination countries in Americas
1
Venezuela (53.9%)
$1.01M
2
Bolivia (28.5%)
$533K
3
Chile (10.9%)
$204K
4
Nicaragua (4.9%)
$92K
5
Peru (0.7%)
$14K
6
Guyana (0.5%)
$9K
7
Honduras (0.2%)
$3K
8
Saint Lucia (0.2%)
$3K
9
Haiti (0.1%)
$3K
10
Anguilla (0.1%)
$2K
11
Brazil (0.0%)
$66.82
Top 5 Indian suppliers into Americas
1
CIPLA LTD
$1.10M
2
EMCURE PHARMACEUTICALS LTD
$519K
3
HETERO LABS LTD
$240K
4
MACLEODS PHARMACEUTICALS LTD
$11K
5
GNH INDIA PHARMACEUTICALS LTD
$66.82
Top 10 Americas importers
1
UNITED NATIONS DEVELOPMENT · Venezuela
$1.01M
2
PROGRAMA DE LAS NACIONES UNIDAS · Bolivia
$533K
3
SEVEN PHARMA CHILE SPA · Chile
$204K
4
CIPS MINISTERIO DE SA · Nicaragua
$89K
5
SEVEN PHARMA S.A · Peru
$14K
6
NEW GPC INC · Guyana
$9K
7
WORLD VISION INTERNATIONAL HAITI · Haiti
$3K
8
CIPS - MINISTERIO DE SA · Nicaragua
$2K
9
WORLD VISION INTERNATIONAL - HAITI · Haiti
$34.17
10
SECRETARIA DE SA · Honduras
$0.0000
Top 4 dosage forms
1
Tablet
$1.15M
2
/tenofovir
$707K
3
Dispersible Tablet
$6K
4
Unknown
$3K
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 8 | $323K | $40K |
| Nov | 17 | $1.02M | $60K |
| Dec | 12 | $531K | $44K |
Shipment register · 37 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — CIPLA LTD · 19 shipments · $1.10M | |||||||||||
| 1 | Oct 2025 | CIPS MINISTERIO DE SA | Nicaragua | Tablet | 980.7K | NOS | $0.089 | $87K | NHAVA SHEVA SEA (JNPT) | Managua | SEA |
| 2 | Oct 2025 | CIPS MINISTERIO DE SA | Nicaragua | Tablet | 21.0K | NOS | $0.089 | $2K | NHAVA SHEVA SEA (JNPT) | Managua | SEA |
| 3 | Nov 2025 | UNITED NATIONS DEVELOPMENT | Venezuela | /tenofovir | 1.2M | NOS | $0.081 | $95K | NHAVA SHEVA SEA (JNPT) | La Guaira | SEA |
| 4 | Nov 2025 | UNITED NATIONS DEVELOPMENT | Venezuela | /tenofovir | 1.1M | NOS | $0.081 | $86K | NHAVA SHEVA SEA (JNPT) | La Guaira | SEA |
| 5 | Nov 2025 | UNITED NATIONS DEVELOPMENT | Venezuela | /tenofovir | 1.2M | NOS | $0.081 | $94K | NHAVA SHEVA SEA (JNPT) | La Guaira | SEA |
| 6 | Nov 2025 | UNITED NATIONS DEVELOPMENT | Venezuela | /tenofovir | 963.9K | NOS | $0.081 | $78K | NHAVA SHEVA SEA (JNPT) | La Guaira | SEA |
| 7 | Nov 2025 | UNITED NATIONS DEVELOPMENT | Venezuela | /tenofovir | 1.2M | NOS | $0.081 | $95K | NHAVA SHEVA SEA (JNPT) | La Guaira | SEA |
| 8 | Nov 2025 | UNITED NATIONS DEVELOPMENT | Venezuela | /tenofovir | 1.2M | NOS | $0.081 | $94K | NHAVA SHEVA SEA (JNPT) | La Guaira | SEA |
| 9 | Nov 2025 | UNITED NATIONS DEVELOPMENT | Venezuela | /tenofovir | 1.1M | NOS | $0.081 | $86K | NHAVA SHEVA SEA (JNPT) | La Guaira | SEA |
| 10 | Nov 2025 | UNITED NATIONS DEVELOPMENT | Venezuela | /tenofovir | 963.9K | NOS | $0.081 | $78K | NHAVA SHEVA SEA (JNPT) | La Guaira | SEA |
| 11 | Nov 2025 | UNITED NATIONS DEVELOPMENT | Venezuela | Tablet | 1.2M | NOS | $0.081 | $95K | NHAVA SHEVA SEA (JNPT) | La Guaira | SEA |
| 12 | Nov 2025 | UNITED NATIONS DEVELOPMENT | Venezuela | Tablet | 1.2M | NOS | $0.081 | $94K | NHAVA SHEVA SEA (JNPT) | La Guaira | SEA |
| 13 | Nov 2025 | UNITED NATIONS DEVELOPMENT | Venezuela | Tablet | 1.2M | NOS | $0.081 | $94K | NHAVA SHEVA SEA (JNPT) | La Guaira | SEA |
| 14 | Nov 2025 | UNITED NATIONS DEVELOPMENT | Venezuela | Tablet | 195.3K | NOS | $0.081 | $16K | NHAVA SHEVA SEA (JNPT) | La Guaira | SEA |
| 15 | Dec 2025 | WORLD VISION INTERNATIONAL HAITI | Haiti | Tablet | 1.2M | NOS | $0.0010 | $1K | NHAVA SHEVA SEA (JNPT) | Laffiteau | SEA |
| 16 | Dec 2025 | WORLD VISION INTERNATIONAL HAITI | Haiti | Tablet | 1.0M | NOS | $0.0010 | $988.05 | NHAVA SHEVA SEA (JNPT) | Laffiteau | SEA |
| 17 | Dec 2025 | WORLD VISION INTERNATIONAL HAITI | Haiti | Tablet | 497.7K | NOS | $0.0010 | $481.83 | NHAVA SHEVA SEA (JNPT) | Laffiteau | SEA |
| 18 | Dec 2025 | WORLD VISION INTERNATIONAL HAITI | Haiti | Tablet | 4.5K | NOS | $0.0010 | $4.36 | NHAVA SHEVA SEA (JNPT) | Laffiteau | SEA |
| 19 | Dec 2025 | WORLD VISION INTERNATIONAL HAITI | Haiti | Tablet | 900 | NOS | $0.0010 | $0.871 | NHAVA SHEVA SEA (JNPT) | Laffiteau | SEA |
| SUPPLIER #2 — EMCURE PHARMACEUTICALS LTD · 1 shipments · $519K | |||||||||||
| 20 | Dec 2025 | PROGRAMA DE LAS NACIONES UNIDAS | Bolivia | Tablet | 69.3K | NOS | $7.50 | $519K | NHAVA SHEVA SEA (JNPT) | Arica | SEA |
| SUPPLIER #3 — HETERO LABS LTD · 9 shipments · $240K | |||||||||||
| 21 | Oct 2025 | SEVEN PHARMA CHILE SPA | Chile | Tablet | 1.5M | NOS | $0.135 | $204K | HYDERABAD AIR | SANTIAGO DE CHILE - | AIR |
| 22 | Oct 2025 | SEVEN PHARMA S.A | Peru | Tablet | 147.8K | NOS | $0.092 | $14K | HYDERABAD AIR | LIMA - | AIR |
| 23 | Oct 2025 | PROGRAMA DE LAS NACIONES UNIDAS | Bolivia | Tablet | 187.2K | NOS | $0.035 | $7K | HYDERABAD AIR | MIAMI, FL | AIR |
| 24 | Oct 2025 | PROGRAMA DE LAS NACIONES UNIDAS | Bolivia | Tablet | 187.2K | NOS | $0.035 | $7K | HYDERABAD AIR | MIAMI, FL | AIR |
| 25 | Nov 2025 | UNLISTED BUYER | Anguilla | Tablet | 144 | NOS | $6.12 | $881.43 | MUMBAI AIR (SAHAR) | ANGUILLA,AI | AIR |
| 26 | Nov 2025 | UNLISTED BUYER | Anguilla | Tablet | 144 | NOS | $4.42 | $636.06 | MUMBAI AIR (SAHAR) | ANGUILLA,AI | AIR |
| 27 | Nov 2025 | UNKNOWN BUYER | Anguilla | Tablet | 144 | NOS | $4.42 | $636.06 | MUMBAI AIR (SAHAR) | ANGUILLA,AI | AIR |
| 28 | Nov 2025 | UNLISTED BUYER | Saint Lucia | 912 | NOS | $3.72 | $3K | MUMBAI AIR (SAHAR) | ST LUCIA | AIR | |
| 29 | Nov 2025 | UNLISTED BUYER | Honduras | Tablet | 132.5K | TBS | $0.026 | $3K | MUMBAI AIR (SAHAR) | TEGUCIGALPA | AIR |
| SUPPLIER #4 — MACLEODS PHARMACEUTICALS LTD · 7 shipments · $11K | |||||||||||
| 30 | Oct 2025 | CIPS - MINISTERIO DE SA | Nicaragua | Dispersible Tablet | 10.2K | NOS | $0.041 | $419.89 | NHAVA SHEVA SEA (JNPT) | Managua | SEA |
| 31 | Oct 2025 | CIPS - MINISTERIO DE SA | Nicaragua | Tablet | 64.5K | NOS | $0.029 | $2K | NHAVA SHEVA SEA (JNPT) | Managua | SEA |
| 32 | Dec 2025 | NEW GPC INC | Guyana | Dispersible Tablet | 57.6K | NOS | $0.052 | $3K | MUMBAI AIR (SAHAR) | GEORGETOWN | AIR |
| 33 | Dec 2025 | NEW GPC INC | Guyana | Dispersible Tablet | 57.6K | NOS | $0.050 | $3K | MUMBAI AIR (SAHAR) | GEORGETOWN | AIR |
| 34 | Dec 2025 | NEW GPC INC | Guyana | Tablet | 57.6K | NOS | $0.047 | $3K | MUMBAI AIR (SAHAR) | GEORGETOWN | AIR |
| 35 | Dec 2025 | WORLD VISION INTERNATIONAL - HAITI | Haiti | Dispersible Tablet | 72.0K | NOS | $0.0005 | $34.17 | NHAVA SHEVA SEA (JNPT) | Laffiteau | SEA |
| 36 | Dec 2025 | SECRETARIA DE SA | Honduras | Tablet | 35.5K | NOS | $0.0000 | $0.0000 | MUMBAI AIR (SAHAR) | TEGUCIGALPA | AIR |
| SUPPLIER #5 — GNH INDIA PHARMACEUTICALS LTD · 1 shipments · $66.82 | |||||||||||
| 37 | Dec 2025 | UNLISTED BUYER | Brazil | Tablet | 160 | VLS | $0.418 | $66.82 | MUMBAI AIR (SAHAR) | Guarulhos | AIR |
10
PART VI — DRILL-DOWN · OCEANIA
Region: Oceania
1 countries · 1 shipments · $744.97 · 1 Indian suppliers · 1 buyers
SHIPMENTS
1
USD
$744.97
COUNTRIES
1
SUPPLIERS
1
BUYERS
1
HHI
10,000
concentrated
Top 1 destination countries in Oceania
1
Vanuatu (100.0%)
$744.97
Top 1 Indian suppliers into Oceania
1
BRINTON PHARMACEUTICALS LTD
$744.97
Top 0 Oceania importers
Top 1 dosage forms
1
Tablet
$744.97
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 0 | $0.0000 | — |
| Nov | 0 | $0.0000 | — |
| Dec | 1 | $744.97 | $744.97 |
Shipment register · 1 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — BRINTON PHARMACEUTICALS LTD · 1 shipments · $744.97 | |||||||||||
| 1 | Dec 2025 | UNLISTED BUYER | Vanuatu | Tablet | 20 | NOS | $37.25 | $744.97 | MUMBAI AIR (SAHAR) | PORT VILA | AIR |
10
PART VI — EVIDENCE REGISTER
Indian Supplier Directory
All 18 Indian dolutegravir exporters — complete list ranked by USD
KEY TAKEAWAY
This directory lists every Indian company that shipped dolutegravir in 2025-Q4.
S FOR SUPPLIERS
Find yourself and your competitors. Compare shipment count, USD, and destination regions.
B FOR BUYERS
Search for potential Indian suppliers. Filter by dosage form and destination region.
| # | Supplier | City | Ships | USD | Dosage forms | Primary regions |
|---|---|---|---|---|---|---|
| 1 | HETERO LABS LTD | HYDERABAD | 44 | $17.13M | Tablet, disopr | Americas, Africa |
| 2 | CIPLA LTD | MUMBAI | 117 | $9.07M | Tablet, /tenofovir | Africa, Americas |
| 3 | EMCURE PHARMACEUTICALS LTD | PUNE-MAHARASHTRA | 19 | $6.10M | Tablet | Africa, Americas |
| 4 | SUN PHARMACEUTICAL INDUSTRIES LTD | MUMBAI | 6 | $2.84M | Tablet | Africa, Europe |
| 5 | M D PHARMACY | Bhopal | 6 | $2.18M | Tablet | Africa |
| 6 | MICRO LABS LTD | VERNA | 4 | $131K | Tablet | Africa, Asia |
| 7 | MACLEODS PHARMACEUTICALS LTD | MUMBAI MAHARASHTRA | 18 | $70K | Dispersible Tablet, Tablet | Americas, Asia |
| 8 | HEET HEALTHCARE PVT LTD | AHMEDABAD | 12 | $31K | Asia, Europe | |
| 9 | APPLE PHARMACEUTICALS | MUMBAI | 2 | $8K | Tablet | Asia |
| 10 | HOPEWELL SOLUTIONS | MUMBAI | 1 | $6K | Tablet | Asia |
| 11 | NIVIRA EXPORTS | MUMBAI | 1 | $3K | Tablet | Europe |
| 12 | SANDOZ PVT LTD | NAVI MUMBAI | 3 | $3K | Tablet | Europe |
| 13 | PINKLINE EXPORTS | JAIPUR | 1 | $3K | Asia | |
| 14 | BRINTON PHARMACEUTICALS LTD | PUNE | 1 | $744.97 | Tablet | Oceania |
| 15 | LEOWIN HEALTHCARE LLP | GANDHINAGAR | 3 | $682.52 | Tablet | Asia |
| 16 | PLEASANT EXPORTS | CHENNAI | 1 | $455.59 | Tablet | Asia |
| 17 | GNH INDIA PHARMACEUTICALS LTD | MUMBAI | 1 | $66.82 | Tablet | Americas |
| 18 | SHARVIK IMPEX (INDIA) PVT LTD | NAGPUR (M.S.) | 1 | $14.61 | Tablet | Africa |
10
PART VI — EVIDENCE REGISTER
Global Buyer Directory
All 53 global dolutegravir importers — complete list ranked by USD
KEY TAKEAWAY
This directory lists every company that imported Indian dolutegravir in 2025-Q4.
S FOR SUPPLIERS
Search for potential customers by country and dosage form.
B FOR BUYERS
Find your company and see which Indian supplier serves you.
| # | Buyer | Country | Ships | USD | Primary supplier | Dosage forms |
|---|---|---|---|---|---|---|
| 1 | NATIONAL EMERGENCY RESPONSE COUNCIL | South Africa | 25 | $3.66M | CIPLA LTD | Tablet |
| 2 | MINISTRY OF HEALTH AND CHILD CARE | Zimbabwe | 33 | $2.76M | CIPLA LTD | Tablet |
| 3 | PROGRAMME NATIONAL DE LUTTE CONTRE | Cote d'Ivoire | 27 | $2.34M | CIPLA LTD | Tablet |
| 4 | MINISTERIO DA SA | Mozambique | 1 | $2.20M | SUN PHARMACEUTICAL I… | Tablet |
| 5 | THE MISSION DIRECTOR | Nigeria | 9 | $1.84M | HETERO LABS LTD | Tablet |
| 6 | OFFICE PHARMACEUTIQUE NATIONAL (OPN | Gabon | 5 | $1.70M | M D PHARMACY | Tablet |
| 7 | NATIONAL DRUGS SERVICE ORGANIZATION | Lesotho | 3 | $1.65M | EMCURE PHARMACEUTICA… | Tablet |
| 8 | EMCURE PHARMACEUTICALS SA (PTY) LTD | South Africa | 5 | $1.63M | EMCURE PHARMACEUTICA… | Tablet |
| 9 | MINISTRY OF HEALTH OF THE | Tanzania | 2 | $1.35M | HETERO LABS LTD | Tablet |
| 10 | UNITED NATIONS DEVELOPMENT | Venezuela | 15 | $1.01M | CIPLA LTD | /tenofovir, Tablet |
| 11 | HOANG DUC PHARMACEUTICAL & | Vietnam | 5 | $606K | HETERO LABS LTD | Tablet |
| 12 | THE MINISTRY OF HEALTH AND SOCIAL S | Namibia | 3 | $551K | EMCURE PHARMACEUTICA… | Tablet |
| 13 | PROGRAMA DE LAS NACIONES UNIDAS | Bolivia | 3 | $533K | EMCURE PHARMACEUTICA… | Tablet |
| 14 | BUREAU DU PNUD UNDP IN CONGOCROISEM | Republic of the Congo | 5 | $367K | CIPLA LTD | Tablet |
| 15 | AO RANBAXY | Russia | 2 | $258K | SUN PHARMACEUTICAL I… | Tablet |
| 16 | SEVEN PHARMA CHILE SPA | Chile | 1 | $204K | HETERO LABS LTD | Tablet |
| 17 | RANBAXY (MALAYSIA) SDN BHD | Malaysia | 1 | $190K | SUN PHARMACEUTICAL I… | Tablet |
| 18 | SECRETARIAT EXECUTIF NATIONAL DE | Mauritania | 5 | $149K | HETERO LABS LTD | disopr, Tablet |
| 19 | NATIONAL COUNCIL FOR THE STRUGGLEAG | Burkina Faso | 2 | $146K | CIPLA LTD | Tablet |
| 20 | MEDICAL SUPPLIES DIVISION MOH OF | Sri Lanka | 2 | $139K | CIPLA LTD | Tablet |
| 21 | MINISTRY OF HEALTH AND CHILD CAREC/ | Zimbabwe | 1 | $122K | EMCURE PHARMACEUTICA… | Tablet |
| 22 | MINISTRY OF HEALTH (CHAS) | Laos | 1 | $98K | CIPLA LTD | |
| 23 | CIPS MINISTERIO DE SA | Nicaragua | 2 | $89K | CIPLA LTD | Tablet |
| 24 | BROWN & BURK PHILIPPINES INC | Philippines | 1 | $87K | MICRO LABS LTD | Tablet |
| 25 | UNDP | DR Congo | 1 | $64K | HETERO LABS LTD | Tablet |
| 26 | MEDPRO PHARMACEUTICA PTY LTD | South Africa | 2 | $54K | CIPLA LTD | Tablet |
| 27 | MINISTRY OF HEALTH & CHILD CARE | Zimbabwe | 1 | $42K | MICRO LABS LTD | Tablet |
| 28 | UNDP SOUTH SUDAN | South Sudan | 1 | $41K | MACLEODS PHARMACEUTI… | Dispersible Tablet |
| 29 | COSPHARM | Namibia | 1 | $20K | HETERO LABS LTD | Tablet |
| 30 | SEVEN PHARMA S.A | Peru | 1 | $14K | HETERO LABS LTD | Tablet |
| 31 | UNITED NATIONS DEVELOPMENTPROGRAMME | Tajikistan | 2 | $13K | CIPLA LTD | |
| 32 | UNDP/GLOBAL FUND PROJECT | Angola | 1 | $13K | EMCURE PHARMACEUTICA… | Tablet |
| 33 | INTERMED ANGOLA, LDA | Angola | 4 | $10K | MACLEODS PHARMACEUTI… | Tablet |
| 34 | NEW GPC INC | Guyana | 3 | $9K | MACLEODS PHARMACEUTI… | Dispersible Tablet, Tablet |
| 35 | EGCSS INTERNATIONAL CO.FZ | United Arab Emirates | 1 | $6K | HOPEWELL SOLUTIONS | Tablet |
| 36 | NATIONAL CENTER FOR HIV/AIDS MINIST | Cambodia | 2 | $6K | EMCURE PHARMACEUTICA… | Tablet |
| 37 | SHIP CLINIC INC | Philippines | 1 | $4K | APPLE PHARMACEUTICALS | Tablet |
| 38 | TO THE PURCHASE DEPT | United Kingdom | 1 | $3K | NIVIRA EXPORTS | Tablet |
| 39 | LEK PHARMACEUTICALS D.D | Slovenia | 3 | $3K | SANDOZ PVT LTD | Tablet |
| 40 | US EMBASSY (C) | Tanzania | 1 | $3K | MACLEODS PHARMACEUTI… | Dispersible Tablet |
| 41 | NSK FORWARDING & TRANSPORTATION | Malaysia | 1 | $3K | PINKLINE EXPORTS | |
| 42 | WORLD VISION INTERNATIONAL HAITI | Haiti | 5 | $3K | CIPLA LTD | Tablet |
| 43 | CIPS - MINISTERIO DE SA | Nicaragua | 2 | $2K | MACLEODS PHARMACEUTI… | Dispersible Tablet, Tablet |
| 44 | M.S. TERMINAL CO LTD | Thailand | 1 | $2K | MACLEODS PHARMACEUTI… | Dispersible Tablet |
| 45 | TRIDENT HEALTHCARE LTD | Mauritius | 1 | $545.42 | HETERO LABS LTD | Tablet |
| 46 | THE ESSES PHARMACY (PVT) LTD | Sri Lanka | 1 | $455.59 | PLEASANT EXPORTS | Tablet |
| 47 | PROGRAMME DES NATIONS UNIES POUR LE | Republic of the Congo | 1 | $431.29 | MACLEODS PHARMACEUTI… | Tablet |
| 48 | THE MAURITIUS PHARMACY (SEEGOBIN) L | Mauritius | 1 | $132.74 | EMCURE PHARMACEUTICA… | Tablet |
| 49 | IDA TRADING MEA | United Arab Emirates | 1 | $47.84 | MACLEODS PHARMACEUTI… | Tablet |
| 50 | WORLD VISION INTERNATIONAL - HAITI | Haiti | 1 | $34.17 | MACLEODS PHARMACEUTI… | Dispersible Tablet |
| 51 | P.F.ASSELBERGS | Madagascar | 1 | $14.61 | SHARVIK IMPEX (INDIA… | Tablet |
| 52 | SECRETARIA DE SA | Honduras | 1 | $0.0000 | MACLEODS PHARMACEUTI… | Tablet |
| 53 | US EMBASSY MBABANE | South Africa | 1 | $0.0000 | MACLEODS PHARMACEUTI… | Tablet |
This report covers 241 2025-Q4 Dolutegravir shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/dolutegravir
Talk to our trade analyst
Need a custom dolutegravir report or a deeper dive into any market? Our team is ready.
WhatsApp: +91 95950 78788 · transdatanexus.com
PHARMA TRADE INTELLIGENCE
Thank you for reading
This report is part of the TransData Nexus Pharma Trade Intelligence series, covering 366 pharmaceutical products exported from India.
Every figure is grounded in real commercial trade records — official customs filings and licensed databases. No surveys, no estimates, no fake data.
Need a custom report?
We can generate intelligence for any pharmaceutical product, any time period, any combination of source and destination countries.
Want deeper analysis?
Our team provides competitive intelligence, market entry strategy, and supply chain due diligence for pharma importers and exporters.
Scan for product page
WhatsApp: +91 95950 78788
Email: info@transdatanexus.com
Web: https://transdatanexus.com/pharmaceutical/dolutegravir
© 2026 TransData Nexus. All rights reserved. This report is provided for informational purposes only.
Data sourced from official customs filings and licensed commercial trade databases.
Reproduction without permission is prohibited.
Explore the full Dolutegravir product page
Live data, supplier directory, price trends, and trade route analysis